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SVA is a composite repetitive element named after its main components, SINE, VNTR 
and Alu. There are ~3000 SVA elements in the human genome. A genomic distribution analysis 
indicates that SVA elements are enriched in G+C-rich regions but have no preferences for inter- 
or intra-genic regions. A phylogenetic analysis of these elements resulted in the recovery of six 
subfamilies that were named SVA_A to SVA_F. The composition, age and genomic distribution 
of the different subfamilies have been examined. Subfamily age estimates indicate that the 
expansion of four SVA subfamilies (SVA_A, SVA_B, SVA_C and SVA_D) began before the 
divergence of human, chimpanzee and gorilla, while subfamilies SVA_E and SVA_F are 
restricted to the human lineage. Furthermore, I examined the amplification dynamics of SVA 
elements throughout the primate order and traced their origin back to the beginnings of hominid 
primate evolution, approximately 18 to 25 million years ago, which makes SVA elements the 
youngest family of retrotransposons in the primate order. Gene duplication is one of the most 
important mechanisms for creating new genes and generating genomic novelty. Retrotransposon-
mediated sequence transduction (i.e. the process by which a retrotransposon carries flanking 
sequence during its own mobilization) has been proposed as a gene duplication mechanism. SVA 
elements are capable transducing 3’ flanking sequence during retrotransposition. I examined all 
the full-length SVA elements in the human genome to assess the frequency and impact of SVA-
mediated 3’ sequence transduction. The results showed that ~53 kb of genomic sequence has 
been duplicated by 143 different SVA-mediated transduction events. In particular, I identified 
one group of SVA elements that has duplicated the entire AMAC gene three times in the human 
genome via SVA-mediated transduction events, which happened before the divergence of 
humans and African great apes. In addition to the original AMAC gene, the three transduced 
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AMAC copies contain intact open reading frames (ORFs) in the human genome and at least two 
are actively transcribed in different human tissues. Thus, duplication of entire genes and creation 
of new gene families via retrotransposon-mediated sequence transduction represent an important 
mechanism by which mobile elements impact their host genomes. 
 
  






























































Mobile elements are interspersed DNA sequences that were first discovered by Barbara 
McClintock in her study of the controlling element at the dissociation locus in the maize genome 
(McClintock 1956; McClintock 1984). They constitute substantial portions of almost all 
eukaryotic genomes sequenced to date. Transposons and retrotransposons are two major types of 
mobile elements utilizing the nucleic acid intermediate for their transposition process. DNA 
transposons possess inverted terminal repeats and encode a transposase protein that they use to 
self-excise from the genome (Mizuuchi 1992; Smit and Riggs 1996). There are no known active 
DNA transposons in the human genome, although active DNA transposons are present in the 
genomes of bacteria, plants and flies (Lander et al.2001). Retrotansposons replicate themselves 
via an RNA intermediate and generate a new copy in the genome (Feng et al. 1996; Luan et al. 
1993; Moran et al. 1996). Due to their “copy and paste” behavior, retrotransposons can 
accumulate fast in the genome and have had a large impact on genomic composition and 
architecture (Deininger and Batzer 2002).  
Retrotransposable elements can be classified as either autonomous or non-autonomous. 
Those elements that encode the machinery necessary for their own mobility are considered 
autonomous. Autonomous retrotransposons are further divided into two subclasses of elements 
depending on whether or not they are flanked by long terminal repeats (LTRs). LTR-containing 
retrotransposons resemble retroviruses in structure, except for the absence of a functional 
envelope (env) gene, the protein product of which is used to transport elements between cells 
(Ono et al. 1987). In humans, the most abundant members of this class are the human 
endogenous retroviruses (HERVs) which comprise ~1-2% of the genome (Lower et al. 1996).  
The non-LTR retrotransposons utilize a promoter sequence located within the 5’ end of 
the coding sequence and make polyadenylated RNAs during their retrotransposition. These 
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RNAs differ from traditional mRNAs in that they are generally bicistronic RNAs that code for an 
RNA-binding protein (ORF1) and an ORF2 protein with endonuclease and reverse transcriptase 
domains (Kazazian 2000). The major non-LTR retrotransposon in humans is the long 
interspersed element (LINE).  
Three different families of LINEs exist in the human genome (i.e., LINE1 (L1), LINE2 
(L2) and LINE3 (L3) ) (Lander et al. 2001). L1s have a long evolutionary history dating back to 
the beginnings of eukaryotic existence. About 520,000 L1s are dispersed throughout the human 
genome to date, accounting for 17% of the genome by mass (Smit 1999). Full-length L1s contain 
about 6kb nucleotides and have a poorly characterized internal promoter at the 5’ end; two open 
reading frames (ORF1 and ORF2); a functional AATAAA polyadenylation (polyA) signal and 
are usually flanked by short duplications of genomic DNA, called target site duplications (TSDs) 
(Moran et al. 1999) (Figure1.1). 
 
Figure 1.1: Full-length L1 structure. Full-length L1 is ~6kb in length. TSDs are shown as 
arrows. 5’UTR, ORF1, ORF2, 3’UTR, polyandenylation signal and polyA tail are indicated. 
 
L1 ORF1 encodes an approximately 40-kDa protein with nucleic acid binding activity. 
The exact size of the ORF1 protein varies among species and sometimes even within species 
(Hohjoh and Singer 1997). L1 ORF2 encodes an approximately 150-kDa protein with 
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endonuclease (EN), reverse transcriptase (RT), and zinc knuckle (a zinc finger-like motif) 
domains (Kazazian and Moran 1998). The L1 EN domain cleaves one strand of double-stranded 
DNA at a large number of genomic sites characterized by the loose consensus sequence, 
AA/TTTT (Feng et al. 1996). The L1 RT domain is thought to function in the nucleus, use 
genomic DNA as primer, and carry out reverse transcription through the relatively simple 
process of target primed reverse transcription (TPRT) (Luan et al. 1993). In humans, the two L1 
ORFs are in frame and are separated by a 63-bp non-coding spacer region that contains stop 
codons in all three reading frames. Unlike humans, mice L1s have two non-overlapping ORFs in 
different reading frames, while rat L1s have two overlapping ORFs (Ostertag and Kazazian 
2001a). 
The active L1 consensus element also contains a functional AATAAA polyadenylation 
(polyA) signal, which is required for RNA polymerase II (Pol II) termination, and proper 
cleavage and polyadenylation. The polyadenylation of L1 after the AATAAA signal suggests 
that Pol II transcribes L1 (Hirose and Manley 1998; McCracken et al. 1997; Osheim et al. 1999). 
However, there are two unusual features of the L1 polyadenylation signal: (i) the AATAAA 
polyadenylation signal of L1 elements is immediately followed by the presumed polyA tail; (ii) 
L1s usually lack important sequences downstream of the polyadenylation site. So L1 elements 
frequently bypass their own polyA signal and use a downstream signal (Moran et al. 1999). This 
process results in the retrotransposition of additional genomic sequence located 3’ of the L1 
element and is called L1-mediated transduction (Boeke and Pickeral 1999). 
L1s are reverse transcribed and integrated into the genome by a process termed target-
primed reverse transcription (TPRT). TPRT was first demonstrated for the R2 element, a site-
specific, non-LTR retrotransposon found in arthropods (Luan et al. 1993). R2 retrotransposons 
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only have one ORF with both Type II restriction endonuclease and reverse transcriptase 
activities. In vitro experiments have demonstrated that the endonuclease domain of the R2 
element cleaves the non-coding strand of its target site, a sequence in the 28S rRNA gene. A free 
3’ hydroxyl terminal at the DNA nick serves as a primer and the R2 RNA is used as a template 
for the reverse transcription reaction. Reverse transcription of the RNA is followed by cleavage 
of the coding strand and integration. Perfect duplications of small stretches of DNA (usually 7-
20 bp) surrounding the original target site, which flank the newly inserted element, are produced 
by TPRT (Luan et al. 1993). 
Several lines of evidence support the hypothesis that L1s also use TPRT to reverse 
transcribe and integrate into the genome. First, in vitro experiments showed that the full-length 
L1 ORF2 protein produces limited TPRT reactions (Cost et al. 2002). Second, most L1s in the 
genome are flanked by perfect 7-20 bp TSD, which is a typical consequence of the TPRT 
reaction. Third, the predicted cleavage site is often located in T-rich region, which is 
complementary to the polyA tail at the 3’ end of an L1 element, suggesting that they could 
indeed be used as a primer for reverse transcription of the L1 RNA. 
The human genome contains 3000-4000 full length L1s.  Among these, only about 80-
100 full length L1s are retrotranspositionally competent  (Brouha et al. 2003; Lander et al. 2001). 
The retrotransposition mechanism of L1s shows cis-preference: the protein products of a 
particular L1 usually bind to the RNA from the same L1, although low levels of trans-
complementation cannot be ruled out (Ostertag and Kazazian 2001a). The vast majority of L1 
elements are truncated at their 5’ ends. This might be due to an inability of the L1 reverse 
transcriptase to copy the entire L1 RNA before disassociating from the RNA. About 25% of 
recently inserted L1s also contain an inversion within their inserted portions, size-ranging from 
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several hundred to fifteen hundred nucleotides in length (Ostertag and Kazazian 2001b). A 
proposed model called “twin priming” is used to explain this phenomenon. In this model, the 
second DNA strand is sometime nicked before the reverse transcription is completed, the 
additional 3’ hydroxyl is then used as the primer to invade the L1 RNA internally. Then the L1 
RNA template is primed by two different primers at two separate locations and the resolution of 
the RNA/cDNA structure causes the typical L1 inversion with a 5’ truncation (Ostertag and 
Kazazian 2001b). 
There are several classes of non-autonomous elements that appear to rely on the L1-
generated enzymatic machinery for their retrotransposition. The most abundant of these are the 
short interspersed elements (SINEs). SINEs are small elements, usually 90-300 bp in length, and 
are transcribed by RNA polymerase III. These elements are either ancestrally derived from tRNA 
genes or the 7SL RNA gene (Daniels and Deininger 1985; Ullu and Tschudi 1984). SINEs use 
internal RNA polymerase III promoters for transcription, which allows these elements to carry 
their promoters to new genomic locations. However, these promoters are also subsequently 
dependent on flanking sequences to stimulate expression levels in vivo (Chesnokov and Schmid 
1996; Roy et al. 2000). SINEs do not contain any protein-coding sequence, and they are 
integrated into the host genome by borrowing a LINE-encoded protein.  
Alu elements are the only known active SINEs within the human genome (Batzer and 
Deininger 2002). These successful elements have freeloaded wildly on the back of their partner 
L1, to produce over 1.2 million copies per haploid genome during the 65 million years of 
evolutionary time (Lander et al. 2001). The full-length Alu element is about 300 bp long, 
composed of two monomers connected by a 19-bp A-rich linker (Figure1.2). Like other non-
LTR retrotransposons, Alu elements are flanked by short TSDs that are remnants of the 
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retrotransposition process. Due to their evolutionary origin as pseudogenes of the 7SL RNA gene, 
Alu elements contain a split RNA polymerase III promoter that is crucial for their amplification.  
 
 
Figure 1.2: Alu element structure. Alu element is ~300 bp in length. Internal RNA polymerase 
III promoter is indicated as A and B boxes. TSDs are shown as arrows. Middle polyA linker and 
polyA tail are indicated. 
 
Although a great number of Alu elements exist in the human genome, only a small subset 
of Alu elements is thought to be retrotranspositionally competent “source genes” (Batzer and 
Deininger 2002; Cordaux et al. 2004). While promoter integrity and the length and homogeneity 
of the polyA tail have been suggested as principal factors in determining the retrotranspositional 
capability of Alu elements, the criteria required for successful retrotransposition are still not fully 
resolved (Cordaux et al. 2004; Roy-Engel et al. 2002). It is also possible that some post-
transcriptional selections of Alu transcripts are involved in the retrotranspositional activity 
(Sinnett et al. 1992). Over the course of primate evolution, mutations within Alu source genes 
have created nearly 30 subfamilies, generating a hierarchy of elements that have amplified over 
defined periods of time (Price et al. 2004). 
  
 8
Unlike L1s and Alu elements, which have been extensively studied (Batzer and Deininger 
2002; Deininger and Batzer 1999; Kazazian 2000; Ostertag and Kazazian 2001a), SVA elements 
represent a new kind of non-autonomous retrotransposons, and only a few studies have been 
conducted to date to elucidate their properties (Ono et al. 1987; Ostertag et al. 2003). The SVA 
element was originally named SINE-R, with the R indicating its retroviral origin (Ono et al. 
1987). In 1994, Shen et al. identified a new composite retroposon, which consisted of the SINE-
R element together with a stretch of sequence sharing similarity with Alu sequences, when they 
studied the structure of the RP gene (Shen et al. 1994). Thus, they named the element SVA after 
its main components, SINE, VNTR and Alu (Shen et al. 1994).  
The full-length SVA element can be divided into five components (Figure 1.3): (1), a 
(CCCTCT)n hexamer simple repeat region located at the 5’ end; (2), an Alu  homologous region, 
usually composed of two anti-sense Alu fragments and additional sequence of unknown origin; 
(3), a variable number of tandem repeat (VNTR) region, composed of a variable number of 
copies of a 35-50 bp repeated sequence; (4), a ~490 bp long SINE  region, which is derived from 
 
Figure 1.3: Full-length SVA structure. Full-length SVA element is ~2kb in length. Various 
Regions of the SVA element are denoted. TSDs are shown as arrows. 
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the 3’end of the env gene and the 3’ LTR  of the endogenous retrovirus HERV-K10 (Ono et al. 
1987); and (5) a polyA tail immediately following a putative polyadenylation signal (AATAAA).  
SVA elements are thought to have been mobilized by L1s (Ostertag et al. 2003). Similar 
to L1s, SVA elements also lack downstream motifs that are important for efficient transcription 
termination. Therefore, when they are transcribed, the RNA transcription machinery sometimes 
skips the element’s own weak polyadenylation signal and terminates transcription using a 
downstream polyadenylation site located in the 3’ flanking genomic sequence. The transcript 
containing the retrotransposon along with the extra genomic sequence is subsequently integrated 
back into the genome through retrotransposition, a process termed transduction. 
SVA elements share the sequence similarity with Alu elements, but lack the internal RNA 
polymerase III promoter of the Alu family. SVA elements may be transcribed by RNA 
polymerase II based on the following reasons: first, SVA elements are too long to be transcribed 
by RNA polymerase III. Second, SVA element has a putative polyadenylation site. According to 
the sequence structure of both types (with and without transduced sequence), polyA tail is an 
added sequence to the element during the retrotransposition event.  In the first type with 3’ 
transduced sequence, the polyA tail at the end of the transduced sequence was not in the genomic 
sequence but was post-transcriptionally added. In the second type with 3’ truncation, an 
alternative polyadenylation site in the SVA element sequence was used, so the transcripts of 
these elements were truncated and the polyA tail was added after the alternative site. The third 
evidence supporting the RNA polymerase II transcription of SVA elements is that an extra G 
nucleotide is present at the beginning of about one third of the SVA elements. This extra G may 
represent the 5’ capping modification of the SVA RNA sequence by RNA polymerase II. Similar 
addition of G caps has been observed in L1s,  and L1 reverse transcriptase has been known to 
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reverse transcribe the 5’ cap structure of the mRNA (Hirzmann et al. 1993; Lavie et al. 2004; 
Volloch et al. 1995). 
SVA elements remain active in the human genome, as demonstrated by their involvement 
in the creation of various diseases. To date, five diseases, caused by either de novo insertion or 
recombination between pre-existing elements, have been reported that are associated with SVA 
elements (Callinan and Batzer 2006; Kobayashi et al. 1998; Legoix et al. 2000; Ostertag et al. 
2003; Rohrer et al. 1999; Wilund et al. 2002). So SVA element is the third known category of 
retrotransposons currently expanding in the human lineage, along with L1 and Alu elements 
(Batzer and Deininger 2002; Ostertag and Kazazian 2001a). 
This dissertation is a detailed study of the SVA family. In chapter two, I primarily 
analyzed the SVA elements on a genome-wide scale. First, I estimated the copy number in the 
human genome and provided the genomic distribution pattern of the SVA elements. In this study, 
I not only examined the subfamily structures of SVA elements within the human genome, but 
also analyzed the relationship between SVA elements and their flanking genomic sequences. 
Second, I traced the origin of the entire SVA family back to the beginning of hominid primate 
radiation and determined the copy numbers of SVA elements in different non-human primate 
genomes. 
In chapter three, I investigated a less well-characterized mechanism that can potentially 
duplicate genes, namely the transduction of flanking genomic sequence associated with the 
retrotransposition of mobile elements. I examined the extent and properties of SVA-mediated 
transduction events to evaluate their evolutionary impact on the human genome. And I identified 
the first case of the entire gene duplication caused by mobile element-mediated transduction in 
the human genome. The results demonstrate that retrotransposon-mediated sequence transduction 
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is not only a mechanism for exon shuffling, but also serves as a novel mechanism for gene 
duplication and the creation of new gene families. 
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Transposons and transposon-like repetitive elements collectively occupy about 44% of 
the human genome. Alu and L1 (long interspersed elements-1) elements account for ~30% of the 
genome sequence and are the most abundant transposable elements in humans (Lander et al. 
2001), while human endogenous retroviruses (HERVs) represent another ~1% of the human 
genome. In addition to the major retrotransposon families, there are smaller families of 
transposons such as SVA, which are receiving increased attention lately due to their recent 
retrotransposition activity in the human genome (Bennett et al. 2004; Ostertag et al. 2003) .  
The SVA element was originally named SINE-R, with the R indicating its retroviral 
origin (Ono et al. 1987). In 1994, Shen et al. identified a new composite retroposon when they 
studied the structure of the RP gene (Shen et al. 1994). This new retroposon consisted of the 
SINE-R element together with a stretch of sequence that shares sequence similarity with Alu 
sequences. Thus, it was named “SVA” after its main components, SINE, VNTR and Alu (Shen et 
al. 1994).  
SVA elements contain the hallmarks of retrotransposons, in that they are flanked by 
target site duplications (TSDs), terminate in a poly(A) tail and they are occasionally truncated 
and inverted during their integration into the genome (Ostertag et al. 2003). In addition, they can 
transduce 3’ sequences during their movement. Therefore, it has been proposed that SVA 
elements are non-autonomous retrotransposons that are mobilized by L1 encoded proteins in 
trans (Ostertag et al. 2003). 
SVA elements remain active in the human genome, as demonstrated by their involvement 
in the creation of various diseases. To date, at least four diseases have been reported related to 
SVA insertions (Callinan and Batzer 2006; Kobayashi et al. 1998; Legoix et al. 2000; Ostertag et 
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al. 2003; Rohrer et al. 1999; Wilund et al. 2002). This makes SVA the third known category of 
retrotransposons currently expanding in the human lineage, along with L1 and Alu elements 
(Batzer and Deininger 2002; Ostertag and Kazazian 2001).  
 To assess the distribution and impact of SVA elements in the human genome, we 
examined all the SVA elements in the human genome reference sequence (Lander et al. 2001). 
Six SVA subfamilies were identified and characterized. For the two human-specific subfamilies, 
the associated insertion presence/absence human genomic diversity was analyzed.  Furthermore, 
we traced the origin of the entire SVA family back to the beginning of hominid primate radiation 
and determined the copy number of SVA elements in different non-human primate genomes. The 
overall distribution of SVA elements showed a significant correlation with genomic G+C content 
and gene density. 
Results 
Copy Number and Genomic Distribution 
Copy Number of the SVA Elements 
In total, 2762 SVA elements were identified in the human genome draft sequence (hg17, 
May 2004 freeze). Together, they account for 4.2 Mb of the genome, with an average density of 
one element per 1.03 Mb. Among them, 1752 elements are full-length, composing 63% of the 
group. The copy number of SVA elements in the chimpanzee genome (panTro1, Nov 2003 
freeze) was also determined. A total of 2637 elements were obtained, with 42% being full-
length. After examining the truncated SVA elements in the chimpanzee genome draft sequence, 
we found that a large proportion of the SVA elements were truncated by stretches of Ns, 
corresponding to unsequenced/unassembled regions of the genome. Therefore, the lower 
proportion of full-length elements in the chimpanzee genome may be due to the lower quality of 
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the chimpanzee draft sequence compared to its finished human counterpart. Detailed wet bench 
estimates of the copy number and phylogenetic distribution of SVA elements throughout the 
primate order are outlined below. 
 
Figure 2.1: Structure analysis of SVA element. (A) Structure of a full-length SVA element 
with the target site duplications. Various Regions of the SVA element are color-coded and 
denoted. (B) Size distribution of SVA VNTR regions. The VNTR regions of SVA elements are 
shown in 100 bp intervals or bins. 
 
The Structure of the SVA Element 
The full-length SVA element can be divided into five components (Figure 2.1(a)): (1), a 
(CCCTCT)n hexamer simple repeat region which is located at the 5’ end; (2), an Alu homologous 
region, usually composed of two antisense Alu fragments and an additional sequence of unknown 
origin; (3), a variable number of tandem repeat (VNTR) region, composed of a variable number 
of copies of a 35-50 bp sequence; (4), a short interspersed element (SINE) region about 490 bp 
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long, which is derived from the 3’end of the env gene and the 3’ long terminal repeat (LTR) of 
the endogenous retrovirus HERV-K10 (Ono et al. 1987); and (5) a poly (A) tail after a putative 
polyadenylation signal (AATAAA). We extracted the VNTR region from all of the full-length 
SVA elements and analyzed their length variation (Figure 2.1(b)). The length of the SVA VNTR 
region varies from 48 to 2306 bp, with an average value of 819 bp. Two-thirds of the SVA 
elements have VNTR lengths in the range of 400-900 bp. 
Genomic Distribution  
To examine the genomic distribution of SVA elements, we first analyzed their 
distribution at the chromosomal level by comparing the observed number of the elements with 
the expected numbers, assuming an infinite sites (random) insertion model (Figure 2.2). In this  
 
 
Figure 2.2: Human genomic distribution of SVA elements. The observed and expected 
numbers of SVA elements from each chromosome are shown.  The expected numbers on each 
chromosome were obtained by multiplying the chromosomal length with average density of 
these elements in the genome.  
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model, the number of insertions on each chromosome was solely proportional to the size of the 
chromosome. A chi-square analysis revealed that the two distributions were significantly 
different (χ2= 78.29, df = 23, p < 0.001), thus leading us to reject the simple random insertion 
model. In particular, the density of SVA elements was found to be much higher than expected on 
chromosomes 1, 17, 19 and 22. On the other hand, chromosomes 4, 5, 13, 18, 21 and Y had far 
fewer elements than expected. A similar non-random chromosomal distribution has previously 
been observed for Alu elements (Carter et al. 2004; Grover et al. 2004).  
Since the properties of the genomic sequence vary greatly among different human 
chromosomes (Lander et al. 2001), we further analyzed the distribution of SVA elements in 
relation to other genomic properties, such as G+C content, gene content and repeat content of the 
flanking nucleotide sequence. At the whole-genome level, we observed a positive correlation 
between SVA density and both G+C content (r = 0.59, p = 0.002) and gene density (r = 0.53, p = 
0.007). In terms of distribution, the SVA elements resemble Alu elements, which are also 
preferentially found in high G+C/gene -rich regions of primate genomes, although the extent of 
correlation is much higher in the case of Alu elements (Lander et al. 2001). In terms of vicinity to 
genes, we observed that 1025 SVA elements reside in intronic regions of the genes and 1737 
elements occur in intergenic regions. Statistically, there is no significant difference (χ2 = 11.48, 
df = 23, p = 0.98) between the number of SVA elements in these two regions.  This result 
suggests that there is no preference for SVA insertion in genes or intergenic regions.  
To examine the SVA distribution in relation to the globe repeat content, we extracted 
nucleotide sequence intervals of 1, 2, 5, 10, 25 and 50 kb from both 5’ and 3’ flanking regions of 
the SVA elements and analyzed the repeat content using RepeatMasker (Table 2.1). We found 
that the repeat content in these different-sized flanking sequences were not significantly different 
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from each other or the overall repeat content in the genome (p > 0.2 in each case). Then, we 
studied individually the two most abundant repeat families, Alu and L1 in these flanking 
sequences. When compared with their expected distribution frequency throughout the genome, 
Alu elements were found to be overly represented in these regions, whereas L1 elements were 
underrepresented (in both cases, p < 0.00001). A closer analysis of the SVA flanking regions 
revealed that the G+C content in the flanking regions is much higher than the genomic average 
(p < 0.00001). Given high Alu density in G+C-rich, and high L1 density  in A+T-rich regions of 
the genome (Lander et al. 2001), these results are not surprising and indicate that SVA elements 
are not preferentially distributed in repeat rich regions of the genome.  
 
Table 2.1: Repeat content and G+C content in the SVA flanking regions. 
  Total Repeat (%) Alu (%) L1 (%) G+C (%) 
  1 kb 43.50 12.40 12.25 42.05 
  2 kb 43.97 12.79 12.62 41.91 
  5 kb 44.18 12.79 12.76 42.85 
10 kb 44.08 12.82 12.74 42.84 
25 kb 43.91 13.02 12.67 43.00 
50 kb 45.12 13.00 12.52 43.06 






Subfamily Structure and Composition 
If SVA elements expanded in a process similar to Alu and L1 elements, a hierarchical 
subfamily structure should be formed. To identify possible subfamily structure, multiple 
alignments of the SVA elements were constructed. Due to the highly variable VNTR region and 
considerable number of 5’ truncated elements, only the LTR derived region (referred to as the S 
part in the following text) was used for the initial analysis. Examination of the alignments 
resulted in the recovery of at least six different groups among the elements based on their 
diagnostic substitutions. Consensus sequences for these groups of SVA elements were generated 
in BioEdit v7.0 (Hall 1999) using a “majority rules” approach. Some of the CpG sites were 
reconstructed manually due to their high mutation rate (Jurka et al. 2002; Xing et al. 2004). 
These subfamilies were named SVA_A to SVA_F. Using a similar approach, one chimpanzee-
specific subfamily was identified and named SVA_PtA. The lineage specific distribution of this 
SVA subfamily was verified by BLAT (blast-like alignment tool) (Kent 2002) comparison to the 
human genome. 
To validate the subfamily definition, multiple alignments were also constructed using the 
Alu related region (referred to as the A part in the following text) together with the S part and 
same groups were identified. Thus, we constructed the human SVA subfamily consensuses 
including both A and S regions of the element. The multiple alignments of the human SVA 
subfamily consensuses along with the corresponding HERV-K10 sequences are available in 
supplemental data (Figure A.1).   
Next, the relative proportions of each SVA subfamily were calculated (Figure 2.3). 




Figure 2.3: SVA subfamily composition in the human genome. The breakdown of SVA 
elements into various subfamilies is shown as a percentage of all the SVA elements in the human 
genome. 
 
of the family. The second largest subfamily, SVA_B, accounts for about 15% of the family. The 
remaining subfamilies (A, C, E and F) have relatively small numbers of elements (<300). Since 
we recognized the SVA subfamilies based on the intact S part of the elements, we could not 
group the elements into subfamilies when they lacked a full-length S part. These truncated 
elements were collectively designated “others” and accounted for 15% of the family. 
SVA Subfamily Age Estimates  
The ages of different SVA subfamilies were estimated using a method similar to that used 
for Alu subfamilies described previously (Xing et al. 2004). Briefly, the S parts of the SVA 
elements in each subfamily were aligned with the subfamily consensus. Next, substitutions in 
this region were divided into CpG and non-CpG substitutions and substitution density was 
calculated using a Perl script. Separate neutral substitution rates of 0.0015/site/million year (myr) 
and 0.0090/site/myr were used for non-CpG and CpG substitution, respectively (Xing et al. 
2004). The substitution density and age estimate of each subfamily are shown in Table 2.2. 
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Given the approximate divergence time of hominid primates (Glazko and Nei 2003; Goodman et 
al. 1998), the age estimates indicate that subfamily SVA_A (13.56 Myrs) may have expanded 
contemporary to the divergence of the orangutan and the great apes (human, chimpanzee and 
gorilla) (12-15 million years ago (Mya)). The expansion of subfamilies SVA_B (11.56 Myrs), 
SVA_C (10.88 Myrs) and SVA_D (9.55 Myrs) may have predated the human, chimpanzee and 
gorilla divergence (~7 Mya). The relatively young age of subfamilies SVA_E (3.46 Myrs) and 
SVA_F (3.18 Myrs) suggested these two subfamilies may have expanded after the human and 
chimpanzee divergence (~4-6 Mya). Indeed, when the human and chimpanzee sequences were 
compared using BLAT, the members of subfamilies SVA_E and SVA_F were absent at 
chimpanzee orthologous loci, confirming their human-specific distribution. 
 













SVA_A 15.13  1.55  16.81 10.30 13.56 
SVA_B 9.53  1.88  10.59 12.53 11.56 
SVA_C 9.73  1.64  10.81 10.94 10.88 
SVA_D 8.50  1.45  9.45 9.64 9.55 
SVA_E 2.21  0.67  2.46 4.47 3.46 




Having obtained age estimates for the SVA subfamilies, we examined the properties of 
SVA VNTR repeat regions as a function of subfamily and age. ANOVA results indicate that 
there are significant (p<< 0.001) differences among subfamilies for VNTR lengths.  With respect 
to age, if the oldest SVA subfamily (SVA_A) is excluded from the analysis, we find a significant 
negative correlation (r2 = 0.96) of VNTR lengths with time (Figure 2.4).  It is unclear why this 




Figure 2.4: The relationship between VNTR lengths and age. Each dot represents one SVA 




G+C Content Distribution, Gene Density and Repeat Density in the Flanking Regions of 
the Subfamilies 
 
A correlation analysis between SVA content and G+C content of all human chromosomes 
was performed to examine the distributions of SVA subfamilies (Figure 2.5). Different levels of 
correlation were observed, with the highest values for the youngest subfamilies SVA_E (r = 
0.75, p = 0.000022) and SVA_F (r = 0.57, p = 0.0035), mild correlation for SVA_D (r = 0.45, p 
= 0.027), and no significant correlation for SVA_A, SVA_B and SVA_C. The general trend 
suggests the enrichment of the youngest SVA subfamilies on the high G+C content 
chromosomes. This distribution is in contrast to Alu and L1 elements, whose younger 
subfamilies are preferentially found in A+T-rich regions  ( Medstrand et al. 2002). 
To examine whether the distribution of SVA subfamilies observed at the chromosomal 
level also exists in different regions within a chromosome, the human genome was separated into 
12 bins based upon their G+C content (Medstrand et al. 2002) and the SVA density in each of 
the bins was calculated. We pooled the subfamilies into three groups according to their ages: the  
oldest subfamilies (A, B and C), the intermediate subfamily (D) and young subfamilies (E and 
F). Their distributions in relation to the genomic G+C content were plotted (Figure 2.6). As 
shown in the figure, SVA elements reside mainly in medium to medium-high G+C-rich regions 
of the genome, with maximum density in the bins that correspond to 42-50% G+C content. 
However, there was a shift in SVA density towards higher G+C bins with a decrease in 
evolutionary age. The older subfamilies (A, B and C) were quite rich in the 40-42% G+C bin, 
where the members of young subfamilies (E and F) were found less frequently. The opposite was 
observed in 48-52% G+C content regions of the genome which were extremely rich in young 






Figure 2.5: Correlation between SVA subfamily distribution and chromosomal G+C 
content. The linear regression is denoted with a continuous line and the 95% confidence 






Figure 2.6: SVA subfamily and genomic G+C content. The bin separations are identical with 
those previously described by Lander et al.  SVA subfamilies are pooled into old (SVA_A, 
SVA_B, SVA_C), intermediate (SVA_D) and young (SVA_E and SVA_F) subfamilies. 
 
The correlation analysis between SVA subfamilies and chromosomal gene content were 
examined and similar results were obtained as in the case of G+C content. Strong correlations 
were obtained from young subfamilies SVA_E (r = 0.77, p < 0.0001) and SVA_F (r =0 .64, p < 
0.001); moderate correlation existed for subfamily SVA_D (r = 0.54, p = 0.007) and SVA_C (r = 
0.47, p = 0.02). The correlations were very low and insignificant for the oldest members of this 
repeat family (SVA_A and SVA_B) (Figure 2.7). This result is not surprising, given that gene 





Figure 2.7: Correlation between SVA subfamilies and chromosomal gene density. The linear 
regression is denoted with a continuous line and the 95% confidence intervals are denoted by the 
broken lines. Correlation coefficients (r) and p values are shown. 
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We next analyzed the repeat distribution in the flanking regions of SVA elements 
belonging to each subfamily (Figure 2.8).  The variations in Alu and L1 contents across different 
subfamilies correspond with the G+C content of the flanking regions. In fact, we observed that 
Alu and L1 element density in these regions is significantly correlated with the G+C and A+T 
content, respectively (p > 0.001). These data suggest that SVA elements are not preferentially 











































Figure 2.8: L1 and Alu densities flanking SVA elements and G+C content. The percentage of 
Alu and L1 elements flanking SVA elements from different subfamilies are shown by the dark 
bars.  The flanking unique sequence G+C content is shown by the line among SVA subfamilies.   
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Human Genomic Diversity of Two Human-specific Subfamilies 
To assess the human genetic diversity related to the SVA elements, elements from 
SVA_E and SVA_F subfamilies were screened for insertion polymorphism on a diverse human 
population panel (see Materials and Methods). In total, 48 members of subfamily SVA_E and 58 
members of SVA_F were surveyed. For SVA_E, 37.5% (18/48) of the elements showed 
insertion presence/absence polymorphism on our panel with a 27.6% (16/58) polymorphism rate 
for SVA_F. The insertion polymorphism rates of these two subfamilies are comparable to the 
human-specific Alu and L1 subfamilies with similar ages (Carter et al. 2004; Myers et al. 2002; 
Otieno et al. 2004; Salem et al. 2003), further demonstrating the contemporary retrotransposition 
activity of the SVA family of retroposons. The detailed insertion allele frequencies, 
heterozygosities and genotypes for the SVA insertion polymorphisms are shown in supplemental 
data Table A.1. 
Evolution of the SVA Elements 
Evolution of SVA Subfamilies 
To examine the relationship among the subfamilies, a median-joining network (Bandelt et 
al. 1999; Cordaux et al. 2004) was constructed using the S part of the subfamily consensuses and 
the corresponding region of HERV-K10 (Figure 2.9). The network analysis indicates that the 
older SVA subfamilies evolved in a single lineage: the SVA_A consensus has the highest 
sequence similarity to the HERV-K10 counterpart, differing by 27 substitutions. SVA_B differs 
from SVA_A by 9 substitutions and a 16 bp deletion is present at the 5’ end of the SVA_B 
consensus as compared to HERV-K10 sequence and the SVA_A consensus. This deletion is 
present in all other subfamily consensuses as well. SVA_C is derived from SVA_B and differs 





Figure 2.9: Median-joining network of the SVA subfamilies. The network of the SVA 
subfamily was reconstructed using the S part of the consensus sequences from each subfamily 
along with the corresponding region of HERV-K10. The lines denote substitution steps, with the 
number of substitutions shown on the top of the lines. The size of each of the circles corresponds 
to the relative size of the subfamily in the human genome. 
 
the older subfamilies, the human-specific SVA_E and SVA_F derived independently from a re-
constructed ancestral sequence, which is only one substitution different from SVA_D differ and 
they differ from SVA_D by 15 and 14 substitutions, respectively. 
Copy Number of SVA Elements in Different Non-Human Primate Genomes 
 To further investigate the evolutionary history of the SVA elements, the copy number of 
SVA elements in different primate genomes was estimated by quantitative PCR (QPCR) using a 
pair of intra-SVA primers. QPCR results from different primates were normalized based on the 
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SVA copy number in the human genome (2762) (Figure 2.10). The result indicated that both 
common chimpanzee (Pan troglodytes) (2769) and pygmy chimpanzee (Pan paniscus) (2646) 
had similar number of elements compared to human, while gorilla (Gorilla gorilla) (2334) 
appeared to have about 400 fewer SVA elements. Nevertheless, given the standard deviations in 
our copy number estimates (90, 163 and 221 in common chimpanzee, pygmy chimpanzee and 
gorilla, respectively), the number of SVA elements in human, chimpanzees and gorilla may not 
be appreciably different. By contrast, orangutan (Pongo pygmaeus), which diverged from gorilla 
about 12-15 myrs ago (Glazko and Nei 2003; Goodman et al. 1998), has fewer than 1000 SVA 
elements. Siamang (Hylobates syndactylus) has about 40 elements and no SVA elements were 
detected in any of the two Old World monkeys (green monkey (Chlorocebus aethiops), rhesus 
macaque (Macaca mulatta)) we examined.  
 
Figure 2.10: SVA copy number in the primate lineage. The signal intensity derived from the 
number of known SVA elements in human genome (2762) was used as standard for the 
estimations from quantitative PCR experiments.  These experiments utilized QPCR of the S part 
of each element to estimate the copy number as outlined in the Materials and Methods.  The 




To verify the QPCR results, the available Old World monkey genomic sequences in the 
NCBI database were searched for SVA elements using BLAST (basic local alignment search 
tool) (Altschul et al. 1990). In addition, the rhesus macaque draft assembly, Mmul_0.1 (UCSC 
version rheMac1) was searched using BLAT. In agreement with the QPCR results, no authentic 
SVA elements were identified from either of the database searches. It is noteworthy that the 
individual components of the SVA elements (Alu region, VNTR region and LTR-derived region) 
are present in the Old World monkey genomes, although the origin or the “composition” of the 
full-length SVA element appears to have happened after the divergence of hominid and Old 
World primates.  
Furthermore, a PCR display assay was performed as described in previous study (Han et 
al. 2005) on the two Old World monkeys (rhesus macaque and green monkey) and four hominid 
primates (pygmy chimpanzee, common chimpanzee, gorilla and gibbon (Hylobates lar)), by 
using two primers specific for the Alu part and SINE-R part of the SVA element (the SVA_Alu 
primer: 5’-ATTGAGCACTGAGTGAACGAGA-3’; and the SVA_SINE-R primer: 5’- 
AGTACCCAGGGACACAAACACT-3’). Although SVA elements were readily isolated from 
all of the hominid primates, none was recovered from either of the two Old World primates.  
Discussion 
Copy Number and Subfamily Composition of SVA Elements  
The total number of SVA elements reported here was based on a whole-genome analysis; 
therefore it is more likely to represent the actual number of  SVA elements in the human genome 
compared to previous studies (Ono et al. 1987; Ostertag et al. 2003). It should be noted here that 
due to the polymorphic nature of some of the young SVA elements, a proportion of the total 
number of elements will not be retrieved from any single reference genome that has been 
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sequenced (Hedges et al. 2004). Therefore the copy number reported here represents the lower 
limit of the number of SVA elements in the human genome.  For the common chimpanzee 
genome, a similar number of elements were identified. However, a large proportion of the SVA 
elements were truncated or flanked by Ns, preventing further investigation of the SVA family in 
the chimpanzee genome. With improvement in the assembly of the common chimpanzee 
genome, a more thorough examination of the SVA elements in chimpanzees can be achieved in 
the future.  
Multiple alignment of the S part of the SVA elements revealed at least six subfamilies 
based on their diagnostic mutations. Aside from the SVA_B and SVA_D subfamilies, the rest of 
the subfamilies have relatively small numbers of elements (<300). The smaller size of a 
particular subfamily could be the result of a relatively short amplification period or the lower 
retrotransposition activity of the source gene(s). The complex nature of the amplification of 
retrotransposons has recently been underscored by the “stealth model” of Alu amplification (Han 
et al. 2005). It remains a possibility that SVA subfamilies with currently low copy numbers are 
simply currently in a state of retrotranspositional quiescence.  
Truncated SVA Elements  
SVA elements were initially named  SINE-R due to their close relationship to the 
endogenous retrovirus HERV-K10 (Ono et al. 1987). The question remained whether the S part 
of the element first originated from HERV-K10 and expanded alone similar to LINE-mediated 
integration of HERV-W (Pavlicek et al. 2002) and the recruitment of the A and VNTR parts 
happened later, or if the SVA element started the expansion as a whole. To address this issue, we 
examined all of the truncated SVA elements. By comparing the sequence of truncated elements 
with the subfamily consensus, we found truncated elements distributed among all the subfamilies 
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we identified. This suggests that SVA elements expanded as one composite unit. Furthermore, 
we examined the alignments of the two oldest subfamilies, SVA_A and SVA_B. The results 
showed that the majority (>70%) of the elements were full-length, containing the A part of the 
elements. These two lines of evidence suggest that the SVA elements were fully 
assembled/composed very early during their expansion as a repeated DNA sequence family. One 
very interesting possibility is that the acquisition of the antisense Alu fragments and the hexamer 
simple repeats changed the properties of the element (e.g. the hexamer simple repeats provided a 
promoter for the element) and initiated the expansion of the SVA family. Additional evidence, 
including cell culture based assays need to be gathered to test this hypothesis. 
The Mobilization of SVA Elements  
Sequence examination of SVA elements showed that, unlike Alu elements, SVA elements 
do not have an RNA polymerase III (pol III) internal promoter. In addition, the full-length 
transcript (~2kb) is too long for normal RNA pol III transcription. As such, it seems likely that 
the SVA element is transcribed by RNA polymerase II (pol II), similar to the L1 elements. 
Indeed, several lines of evidence support this concept: first, SVA has a putative polyadenylation 
site and the poly(A) tail is added to the element during the retrotransposition. Two types of 
integrations clearly showed the addition of poly (A) tails: (1), in elements with 3’ transduced 
sequence, the poly (A) tail at the end of the transduced sequence was not in the genomic 
sequence but was post-transcriptionally added; (2), in 3’ truncated elements, an alternative 
polyadenylation site in the SVA element sequence was used so the transcripts of these elements 
were truncated and the poly(A) tail was added after the alternative site. Second, an extra G was 
present at the beginning of about one-third of the SVA elements. This extra G may represent the 
5’ capping modification of the SVA RNA sequence by RNA pol II. Similar addition of G 
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residues has been observed for L1 elements (Lavie et al. 2004) and reverse transcriptase has been 
known to reverse transcribe the 5’ cap structure (Hirzmann et al. 1993; Volloch et al. 1995). 
If SVA elements are indeed transcribed by RNA pol II, do they have their own promoters 
or do they rely on the promoter activity of their flanking regions? We believe SVA elements may 
rely on both approaches. At least 10% of SVA elements have 3’ transductions and can be traced 
to different origination points. The possibility that most of these several hundred elements have 
fortuitously integrated right after a viable promoter is remote. We believe that these active 
elements bear a functional promoter region and are capable of transcription by themselves. By 
contrast, there is at least one 5’ transduced SVA element which suggests that SVA may be able 
to use a 5’-flanking promoter.   
Genomic Distribution of SVA Elements 
Initial analysis suggested that the genomic distribution of SVA elements was more 
similar to Alu elements than to L1s. However, when we studied each SVA subfamily 
individually, apparent differences were observed between the distributions of SVA and Alu 
elements. The distribution of the youngest SVA elements showed an apparent enrichment in the 
G+C-rich regions in the genome, with a peak at 48-50% G+C content. When the age of the SVA 
elements increased, the enrichment of the elements became less apparent and the peak of 
distribution shifted towards the more A+T-rich regions. By contrast, young Alu subfamilies are 
found in more A+T-rich regions while the enrichment shifts to more G+C-rich regions over time 
(Lander et al. 2001). Thus, although the overall distributions of Alu and SVA elements are both 
in G+C-rich region, the shifting of their G+C distribution patterns are opposite.  
Several scenarios could explain the data noted above. For instance, if SVA elements 
prefer to insert in A+T-rich regions, the distribution of the elements may be due to positive 
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selection acting on the young elements in the G+C-rich regions. The positive selection 
hypothesis requires selection to be acting on the majority of the SVA elements and will result in 
the fixation of the elements that are under selection in a short period of time. However, the ~30% 
polymorphism observed for the two human-specific subfamilies (<4 Myrs old) is consistent with 
neutral expectations. Therefore, positive selection is unlikely to be the causative factor for the 
observed scenario. Another possibility is that elements were preferentially removed from the 
A+T-rich regions. The removal of Alu elements from A+T-rich regions due to unequal  
homologous recombination is thought to contribute to the shifting of  the Alu distribution pattern 
over time (Hackenberg et al. 2005; Pavlicek et al. 2001). But given that there is one SVA every 
1.03 Mb on average (compared to one Alu every 3 kb), the probability of a large scale removal of 
the elements via this type of recombination seems remote. Nevertheless, due to the relatively low 
copy number of SVA elements, less recombination-related problems may be generated as 
compared to L1 elements. This may give the SVA elements a better chance to be fixed in G+C-
rich regions. The possibility remains that this fixation advantage of SVA elements in G+C-rich 
region combining with other unknown mechanisms shifted their distribution over time.  
Another possibility is that SVA elements preferentially inserted in the G+C-rich regions. 
Under this hypothesis, more SVA elements would have to be removed from G+C-rich regions 
over time to generate the observed shift in the distribution. However, this seems counter-intuitive 
for at least two reasons. Firstly, SVA elements are quite possibly using the retrotransposition 
machinery as L1 and Alu elements, (Ostertag et al. 2003) and both young Alu and L1 elements 
are found more common in the A+T-rich regions of the genome (Lander et al. 2001). Secondly, 
the G+C-rich regions are known to have higher gene densities; therefore, the insertion of 
retroelements in these regions will have a larger chance of influencing gene expression and 
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causing genetic defects. Nevertheless, we have no evidence to rule out the possibility of the 
changing insertion preference at this moment. In addition to these scenarios, other mechanisms 
such as compositional matching (Gu et al. 2000) may also have played a role in shaping the SVA 
distribution. 
Our observations in this study bring up an interesting question: if Alu, L1 and SVA 
elements are indeed all retrotransposed using the L1 enzymatic machinery, why are there such 
dramatic differences among their distributions? Multiple scenarios have been proposed for the 
shifting of the Alu distribution to G+C-rich regions, yet the topic remains intensively debated  
(Brookfield 2001; Cordaux et al. 2004; Gu et al. 2000; Hackenberg et al. 2005; Jurka et al. 2004; 
Lander et al. 2001; Ovchinnikov et al. 2001; Pavlicek et al. 2001; Rynditch et al. 1998). The 
observed distribution of the SVA elements undoubtedly added another interesting dimension to 
the overall retroelement genomic distribution puzzle. 
The Impact of SVA Elements  
Similar to other mobile elements, the insertion of SVA elements in the genome may have 
a profound impact on the genomic architecture and stability (Batzer and Deininger 2002; 
Deininger et al. 2003; Ostertag and Kazazian 2001). One of the properties of the SVA elements 
is their high G+C content. A typical full-length element has about 60% G+C content while the 
G+C content of the VNTR region may even exceed 70%. This makes each SVA element a 
potential mobile CpG island and the insertion of the element may influence the surrounding 
genomic environment. SVA elements are also enriched in potential functional units, including 
SP1 binding sites (GGCGG) in the VNTR region and hormone responsive elements (HRE) in the 
S part, to name a few. Since many of these units are harbored in the repetitive regions (both of 
the hexamer repeat region and the VNTR region), multiple copies can be found in a single 
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element. If inserted near a gene, SVA elements may influence the gene expression pattern.   An 
examination of SVA insertions adjacent to the 5’ end of annotated genes indicated that 
approximately 200 elements integrated within 5000 bp upstream of annotated genes in the UCSC 
May 2004 (hg17) human genome assembly. Each of these elements has the potential to alter the 
transcription of the nearby genes. However, detailed studies of gene expression will be required 
to accurately determine the impact of these elements on gene expression.  
What is certain, however, is that SVA can have a negative impact on the genome. To 
date, four cases of different diseases have been reported related to the SVA insertions 
(Kobayashi et al. 1998; Ostertag et al. 2003; Rohrer et al. 1999; Wilund et al. 2002). The 
existence of diseases caused by SVA insertions, along with the presence of partial SVA 
transcripts in dbEST (data not shown), provide strong evidence for the ongoing amplification of 
SVA elements in the human genome.  However, as a result of their relatively lower copy number 
(<3000), SVA elements are likely to have a much lower mutagenic recombination-based impact 
on the genome as compared to the more abundant Alu and L1s. In fact, only one case of disease 
caused by SVA-mediated recombination has previously been reported (Legoix et al. 2000). 
Similar to L1s, SVA elements sometimes bypass their own polyadenylation site and use a 
downstream site, a phenomenon known as “transduction” (Moran et al. 1999; Ostertag and 
Kazazian 2001). In our study, we found ~10% of the SVA elements transduce sequence at their 
3’ end. The transduced sequence ranged from several base-pairs to several thousand base-pairs 
and some of them contained coding sequences. The ability of SVA elements to utilize 3’ 
transduction to shuffle genetic material represents another impact that SVA elements have on the 
genome. In some cases, this so-called “exon shuffling” may generate new proteins with novel 
functions (Moran et al. 1999).  
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Evolution of SVA Elements 
The evolutionary history of SVA retroposons was examined using human SVA elements. 
Since large amounts of genomic sequence data are not yet available for all primate species, we 
employed a QPCR-based approach to estimate the copy number of SVA elements in other 
primate genomes. QPCR has been proven useful in estimating DNA copy number (Alonso et al. 
2004; Ginzinger et al. 2000; Walker et al. 2003), because there is a quantitative relationship 
between the amount of DNA target sequence and the amount of PCR product generated at any 
given PCR cycle prior to saturation. The copy number estimates in different primates and the age 
estimates of SVA subfamilies generated congruent scenarios for the evolution of the SVA 
elements (Figure 2.11): the SVA elements originated before the divergence of hominid primates 
but after the divergence of hominid and Old World primates. The evolutionary history of SVA 
elements is characterized by two major expansion periods: subfamilies SVA_A and SVA_B 
were expanded before the divergence of great apes (orangutan, gorilla, chimpanzee and human). 
Another major expansion of the SVA family occurred after the divergence of orangutan and the 
rest of the great apes. This major expansion is characterized by the amplification of subfamily 
SVA_D, which caused the number of SVA elements in human/chimp/gorilla to be higher than 
other species. The SVA_C subfamily may have also expanded during this period. After the 
divergence of gorilla from human and chimpanzee, SVA family showed lineage-specific activity, 
sprouting two human specific subfamilies. The independent expansion of multiple SVA 
subfamilies in the human genome indicates the existence of multiple SVA source genes, similar 
to Alu elements in the human genome (Cordaux et al. 2004).  
As mentioned earlier, the evolutionary history of SVA elements was examined using the human 
lineage as a starting point.  Even though the QPCR primers were designed in a well-conserved 
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region of the human SVA consensus, there is still insufficient data about the actual structure of 
SVA elements in other non-human primate genomes. The possibility remains that species-
specific SVA insertions or even subfamilies exist in other hominid primates and can not be 
detected using QPCR based assays; thus, we can not rule out that our QPCR results may 
underestimate the SVA copy numbers in more divergent species. Additional studies are needed 




Figure 2.11: Amplification dynamics of the SVA family of retroposons in primates. Putative 
evolutionary history of the SVA lineage in primate genomes. A schematic of the hominid 
primate radiation is shown. The estimated copy number of SVA elements in various primate 
genomes is shown next to their names. The estimated time of origin and period of expansion for 





The SVA family of retroposons represents the third known category of mobile elements 
whose de novo mobilization results in human genetic disorders. Until now, little was known 
about the distribution and properties of these elements in the human genome as compared to Alu 
and L1 elements. In this study, we identified and characterized all of the SVA elements from the 
draft sequence of the human genome.  In addition, the human genomic diversity associated with 
polymorphic SVA elements as well as the phylogenetic distribution of SVA elements was 
examined. By adding the contribution of the SVA family to our current knowledge of mobile 
elements, this study provides a more comprehensive picture and will further enhance our 
understanding of the impact of mobile elements on primate genomes. 
Materials and Methods 
Genome Analysis 
The RepeatMasker annotations of the human (hg17, May 2004 freeze) and chimpanzee 
genomes (panTro1, Nov. 2003 freeze) were obtained from the UCSC Genome Bioinformatics 
Site (http://genome.ucsc.edu/). The locations of SVA elements were then extracted and inspected 
manually. Due to the highly variable VNTR region in SVA elements, some of the annotations 
did not correctly recognize the composition of the elements. In those cases, the annotations were 
edited manually. 
Next, the SVA elements, along with 2000 bp flanking regions on both sides, were 
extracted from the human genomic sequence using a Perl script. The LTR derived region of each 
element was then extracted manually and aligned using Clustal_X (Thompson et al. 1997). For 
the age estimates, elements in each subfamily were aligned and subjected to further manual 
adjustment by removing insertions and poly(A) tails. For enhancing the quality of our data, any 
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element that contained a deletion larger than 50 bp or could not be confidently aligned was also 
excluded from the alignment. 
To study the SVA chromosomal distribution, human chromosome sizes and gap sizes 
were obtained from summary tables from the UCSC website. The information about genes, G+C 
content and nucleotide sequence of each chromosome was also downloaded from the same 
resource. For subfamily G+C analysis, the fraction of elements in each G+C bin were divided by 
the fraction of genome in that bin and the resulting ratio was used as measure of SVA density 
(Lander et al. 2001; Medstrand et al. 2002). Custom-made Perl scripts were used to calculate 
SVA density in G+C bins as well as in genes and intergenic regions, extract flanking sequences 
of various sizes, extract VNTR regions from full-length SVA elements and calculate their sizes. 
Repeat identification in the SVA flanking regions was annotated using a local installation of the 
RepeatMasker program. 
Statistical Analysis 
STATISTICA (version 6.1) was used in the statistical analysis. The chi-squared test was 
used to analyze chromosomal distribution of SVA elements and to compare their inter- and intra-
genic densities. Correlation analysis was performed to examine the relationship between SVA 
elements and genes/G+C content at chromosomal level, as well as Alu and L1 densities in the 
SVA flanking regions with the G+C content. Repeat densities in the flanking regions were 
compared with each other using a pair-wise Student’s t-test. 
Oligonucleotide Primer Design and PCR Analysis 
Because the PCR amplicon of a typical SVA locus is usually larger than 2 kb, two 
separate PCRs were performed in an assay designed for L1 elements as previously described 
(Myers et al. 2002; Sheen et al. 2000). For the filled site PCR, an SVA-specific internal primer 
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(located in the element) and a 3’ flanking unique primer were used to genotype the presence of 
the filled alleles of SVA insertions. For the empty site PCR, two flanking unique primers were 
used to genotype the empty alleles. The SVA presence/absence polymorphism can be determined 
by combining these two results. In this assay, 20 individuals from each of four geographically 
diverse human populations (European, African American, Asian and South American) were 
surveyed for the presence and absence of SVA elements. DNA samples from each of these 
populations were available from previous studies or were purchased from the Coriell Institute for 
Medical Research (Camden, New Jersey). The primers and annealing temperatures for each 
locus are shown in supplemental data Table A.2. 
Other DNA samples used in this study including human genomic DNA (HeLa cell line 
ATCC CCL-2) and nonhuman primate species: DNA samples of Pan troglodytes (common 
chimpanzee), Pan paniscus (pygmy chimpanzee), Gorilla gorilla (western lowland gorilla), 
Pongo pygmaeus (orangutan) and Macaca mulatta (rhesus monkey) are available as a primate 
phylogenetic panel PRP00001 from Coriell. DNA samples of Hylobates syndactylus (siamang) 
were also purchased from Coriell (PR00721). DNA samples of Chlorocebus aethiops (green 
monkey) were isolated from cell lines ATCC CCL70.  
Quantitative PCR 
SYBR® Green PCR core reagents kits were purchased from Applied Biosystems (Foster 
City, CA). Quantitative PCR was carried out in 50μl total volume reactions containing 1.25 units 
AmpliTaq GoldTM DNA polymerase, 5μl 10X SYBR® Green PCR buffer, 3mM MgCl2, 1mM 
dNTP, 0.5mM forward (SVA_SF 5’-ACAAACACTGCGG AAGGCC-3’) and reverse (SVA_SR 
5’-AGGTCTCTGGTTTTCCTAGGCA-3’) primers and 1.0 μl of DNA sample. Four serial 
dilutions of template DNA (10ng, 1ng, 100pg, 10pg) were used for each primate species. 
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Amplification reactions were performed in an ABI Prism 7000 Real Time PCR System (Applied 
Biosystems) following the manufacturer’s instructions with conditions set as follows: 95oC, 12 
min; 40 cycles of 95oC, 15 sec and 68oC, 1min. A standard curve was constructed by using serial 
dilutions of known human genomic DNA samples ranging from 10ng to 10pg. The human DNA 
samples were included as standard with each batch of quantitation reactions. The data from three 
identical reactions were exported from the ABI Prism 7000 System SDS Software (Applied 
Biosystems) into a Microsoft Excel spreadsheet and the copy number of the elements in each 
species was calculated based on the standard curve in each reaction. The mean values and 
standard deviations were calculated based on the three replications.    
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The emergence of new genes and biological functions is crucial to the evolution of 
species (Long et al. 2003). Several mechanisms for creating new genes are known, the best 
characterized pathway being through duplication of preexisting genes (Long et al. 2003; Ohno 
1970). Several types of duplications leading to genetic innovation have been investigated, 
including segmental duplication (Johnson et al. 2001) and gene retrotransposition (Marques et al. 
2005; Nisole et al. 2004; Sayah et al. 2004; Vinckenbosch et al. 2006). Here, we investigate a 
less well characterized mechanism that can potentially duplicate genes, namely the transduction 
of flanking genomic sequence associated with the retrotransposition of mobile elements.  
Retrotransposons usually do not carry downstream motifs that are important for efficient 
transcription termination. Therefore, when they are transcribed, the RNA transcription 
machinery sometimes skips the element’s own weak polyadenylation signal and terminates 
transcription using a downstream polyadenylation site located in the 3’ flanking genomic 
sequence. The transcript containing the retrotransposon along with the extra genomic sequence is 
subsequently integrated back into the genome through retrotransposition, a process termed 3’ 
transduction (Holmes et al. 1994; Moran et al. 1996). In principle, this could lead to the 
duplication of coding sequences located in the transduced flanking genomic sequence. Indeed, 
the exon shuffling and genetic diversity of the L1 mediated 3’ transduction has been 
demonstrated in cell culture assays (Moran et al. 1999; Moran et al. 1996). However, among all 
the studies investigating L1-mediated exon shuffling (Ejima and Yang 2003; Goodier et al. 2000; 
Lander et al. 2001; Pickeral et al. 2000; Rozmahel et al. 1997; Szak et al. 2003), only two 
putative examples of exon transduction have been reported in the human genome (Ejima and 
Yang 2003; Rozmahel et al. 1997). 
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The SVA family of retrotransposons originated less than 25 million years ago (mya) and 
has increased to about 3,000 copies in the human genome (Ostertag et al. 2003; Wang et al. 
2005). Similar to L1 elements, SVA elements are thought to be transcribed by RNA polymerase 
II and have the ability to transduce downstream sequence (Ostertag et al. 2003). About 10% of 
human SVA elements appear to have been involved in sequence transduction events (Wang et al. 
2005). Here, we examined the extent and properties of SVA-mediated transduction events to 
evaluate their evolutionary impact on the human genome. Our results demonstrate that 
retrotransposon-mediated sequence transduction is not only a mechanism for exon shuffling, but 
also serves as a novel mechanism for gene duplication and the creation of new gene families. 
Results and Discussion  
Genomic Analysis for SVA 3’ Transductions 
To investigate the extent of transduction events associated with SVA elements, we 
examined all 1752 full-length SVA elements in the human genome reference sequence. In total, 
143 SVA elements with putative transduced sequences were identified according to our 
validation criteria (Figure 3.1, see materials and methods for details). Most of these loci 
(123/143) also displayed typical AATAAA or ATTAAA polyadenylation signals located 5-52 
nucleotides upstream of the start of the poly(A) tail, further supporting that these loci represent 
authentic SVA-mediated transduction events. The size of the transduced sequences ranged from 
35 to 1853 bp, with an average of 340 bp (Figure 3.2).  Overall, 52,740 bp of genomic sequence 
was duplicated by these SVA mediated transductions. To determine if the transduction events are 
specific characteristics of particular SVA subfamilies, SVA elements with transduced sequence 
were aligned and compared to all known SVA subfamily consensus sequences (Wang et al. 
2005). We found transduction events involving all previously identified SVA families, 
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suggesting that 3’ transduction is a common phenomenon among SVA members (Table 3.1). 
Given that full-length SVA elements comprise 63% of the family, we extrapolate that SVA 
elements may have transduced a total of ~84 kb of genomic sequence during their expansion.  
Table 3.1: Affiliation of 3’ transduced sequences and SVA subfamilies. 
Subfamily A B C D E F Total 
Number of transduction events 4 29 20 72 11 7 143 
Number of full length elements 104 323 151 931 95 148 1752 




Figure 3.1: Identification of SVA 3’ transduction events and their source elements. chematic 
diagrams for the identification process. Flanking sequences of the source locus are shown as blue 
boxes; TSDs are shown as yellow and green arrows. SVA elements are depicted as red bars, and 
the transduced sequences are shown as blue bars and labeled as “TD”. SVA element poly (A) 
tails are shown as “(AAA)n”. The numbers in parentheses correspond to total number of SVA 




Figure 3.2: Length distribution of 3’ transduction events.  Number of human SVA  
mediated 3’ transduction events in each 100 bp size interval. 
 
The rate of SVA-mediated transduction events (8.2%) is similar to the L1 transduction 
rates reported in previous studies (Goodier et al. 2000; Pickeral et al. 2000; Szak et al. 2003). 
Our results are likely to be an underestimate because the method we used to validate candidate 
transductions relied on the detection of perfect target site duplications (TSDs). This requirement 
may miss transduction events as a result of substitutions in their TSDs. Detailed information 
concerning all the SVA transduction events reported in this paper can be found in supplemental 
data Table A.3.   
Identification of Transduction Source Loci  
To identify the source loci of the transduced sequences, we searched the human genome 
using the BLAST-like alignment tool (BLAT) (http://genome.ucsc.edu/cgi-bin/hgBLAT). With 
the exception of 19 loci in which the transduced sequence was totally composed of repetitive 
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sequences or source loci were located in segmental duplications (Figure 3.1) and thus could not 
be mapped precisely to any location in the human genome, we were able to identify the source 
loci for each of the other 124 transductions. While 98 transduced loci could be uniquely linked to 
their source locus and each of them was treated as a unique group, the remaining 26 transduced 
loci showed >95% sequence identity with at least one other transduced locus and were mapped 
to the same source locus. Hence, the 26 transduced loci were assigned to 11 transduction groups 
each of which contained two or more transduced loci.  
Seven out of the total 109 source loci contained an SVA element (Figure 3.1). These source SVA 
elements could be unambiguously identified because only the SVA elements were surrounded by 
TSDs. By comparison, in the transduced loci, the TSDs included both the SVA element and the 
transduced flanking genomic sequence. The source SVA element for the transduction group 
H3_186 located on human chromosome 2p11.2 represented one of the most active elements we 
identified, given that it generated at least nine transduced copies (Figure 3.3). Sequence 
comparisons showed that the source locus and all nine transduced loci were absent from the 
chimpanzee genome. This result suggests that the source locus inserted in the human genome 
after the human-chimpanzee divergence and generated all the loci with transductions within the 
last ~6 million years. Among the nine transduced loci, five were typical SVA transduction loci 
(i.e. having both the SVA element and the transduced sequence) while four loci contained only 
the transduced genomic sequences. Although there is no SVA element upstream of these 
sequences, a poly (A) tail can be found downstream of the transduced sequence and the TSDs 
surrounding the transduced sequence are identifiable. Presumably, these loci were generated via 
SVA-mediated transduction events associated with 5’ truncation during the integration process 
or through incomplete reverse transcription during retrotransposition. SVA represents one of the 
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most active retrotransposon families in humans (CSAC 2005) and little is known about their 
retrotransposition mechanism. Because the source loci with SVA elements may be capable of 
retrotransposition, detailed analysis of the seven transduction source loci we identified in this 
study may shed new light on the underlying mechanism of SVA retrotransposition. 
 
 
Figure 3.3 : SVA 3’ transduction events. One group of SVA 3’ transduction events (H3_186). 
Flanking sequences of the original locus are shown as blue boxes while the flanking sequences 
of the transduced loci are shown as light blue boxes. TSDs are shown as yellow and green 
arrows. SVA elements are depicted as red bars and the transduced sequences are shown as blue 
bars and labeled as “TD”. SVA element poly (A) tails are shown as “(AAA)n”.  
 
For the other 102 source loci, only sequences corresponding to transduced sequences 
were present. Each of the loci was devoid of the SVA elements, TSDs and poly (A) tails. The 
simplest explanation for this genomic configuration is that the retrotransposition events carrying 
transduced sequence occurred while the source SVA element was polymorphic for insertion 
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presence/absence in the population. Subsequently, the original locus with the source SVA 
element may have been lost in the population, or may still be polymorphic in the human 
population but absent from the human genome reference sequence. To test source loci for 
insertion polymorphism, we genotyped 30 source loci in 80 diverse human genomes using 
polymerase chain reaction (PCR) assays as described previously (Wang et al. 2005). No source 
loci containing an SVA element were present in any of the diverse human genomes that were 
surveyed for the 30 SVA source elements. These results suggest that most of the SVA elements 
that generated transduction events were subsequently lost from the human genome. This 
observation is not surprising since similar results have been observed in L1-mediated 
transduction studies (Boissinot et al. 2001; Szak et al. 2003). In fact, the majority of new mobile 
element insertions are expected to be lost from the population due to genetic drift under neutral 
evolution. A second potential reason for the disappearance of these source elements may be 
moderate negative selection as a result of their transcription and retrotransposition capacity 
(Boissinot et al. 2001).  
SVA Transduction Mediated Gene Duplication 
One particularly interesting example of SVA-mediated 3’ transduction is the H17_76 
group (Figure 3.4A), in which four related loci were identified in the human genome. The source 
locus (chr17_A) contained only the transduced sequence without the SVA element and the other 
three loci (chr17_B, chr18 and chr8) contained an SVA element along with the transduced 
sequence resulting from retrotransposition. This group of transduced sequences is among the 
longest of all the elements we recovered (1682 bp, 1245 bp and 1257 bp for loci chr17_B, chr18 
and chr8 respectively). Subsequent analysis of the transduced sequences resulted in the 




Figure 3.4: SVA transduction mediated gene duplication. (A) Schematic diagram of the 
H17_76 transduction group in the human genome. Flanking sequences of the original locus 
are shown as blue boxes while the flanking sequences of the transduced loci are shown as light 
blue boxes. TSDs are shown as yellow and green arrows. SVA elements are depicted as red bars 
and the transduced sequences are shown as blue bars and coding regions are shown as purple 
bars. SVA element poly (A) tails are shown as “(AAA)n”. (B) Schematic diagrams for 
putative evolutionary scenarios of the SVA transduction mediated gene duplications. About 
7 to 14 mya ago, one active SVA element inserted upstream of the original AMAC gene locus. 
Then, transcription of this active SVA element transduced the full length AMAC gene sequence. 
During the retrotransposition process, the intron of the gene was removed by RNA processing 
machinery. Finally, the SVA element along with the intronless AMAC gene sequence 
retrotransposed into new genomic locations. The original retrotransposition competent SVA 
element upstream of the source locus was eventually lost in the population. The predicted RNA 
transcripts are shown as curved lines. (C) The phylogenetic relationships among various 




at the chr17_B locus, AMAC1L1 (AMAC1-like 1, Entrez Gene ID: 492318) at the chr18 locus, 
AMAC1L2 (AMAC1-like 2, Entrez Gene ID: 83650) at the chr8 locus and AMAC1L3 (AMAC1-
like 3, Entrez Gene ID: 404029) at the chr17_A locus. Interestingly, the source locus (chr17_A) 
contains 467 bp of extra sequence in the middle of the transduced sequence as compared to the 
other copies. Examination of the gene structure showed that AMAC1L3 at the inferred source 
locus had two exons separated by an intron (the extra DNA sequence) while the three SVA 
transduced loci contained intronless versions of AMAC1L3 (Figure 3.4A). These results suggest 
that the intron was spliced out during the retrotransposition process, providing further evidence 
for the underlying mechanism that created the three duplicated copies (Figure 3.4B). Although 
the exact function of  human AMAC genes has not been determined, studies in bacteria showed 
that AMAC is an enzyme involved in fatty acid synthesis, in which it condenses a two-carbon 
unit from malonyl-(acyl carrier protein) to fatty acyl-(acyl carrier protein), adding two carbons to 
the fatty acid chain with the release of carbon dioxide (Toomey and Wakil 1966).  
Evolutionary Analyses of AMAC Genes 
To determine the evolutionary history of AMAC transduction events, we first used BLAT 
to search for orthologous loci corresponding to all four human AMAC genes in four available 
mammalian genome sequences (mouse, rat, cow, dog). The search resulted in the identification 
of a single AMAC locus in all four species examined, and it was orthologous to the human 
AMAC1L3. In particular, the mouse orthologous region is annotated as the gene AMAC1 (Entrez 
GeneID: 56293). The murine AMAC1 gene contains two exons similar to human AMAC1L3 
gene. Only the human AMAC1L3 locus was co-linear with the mouse AMAC1 genomic 




Next, we investigated the origin of the multiple AMAC gene copies within the primate 
lineage by analyzing seven non-human primate species (i.e. pygmy chimpanzee, common 
chimpanzee, gorilla, orangutan, siamang, African green monkey and rhesus monkey). PCR and 
DNA sequence analyses showed that the intron-containing locus AMAC1L3 is present in all 
species examined. By contrast, the AMAC1 and AMAC1L2 loci were present only in human, 
pygmy chimpanzee, common chimpanzee and gorilla genomes. Due to the presence of repetitive 
elements in the flanking regions, the AMAC1L1 locus could not be successfully amplified using 
PCR and was excluded from subsequent analyses. Taken together, our results suggest that the 
transduction events happened after the divergence of African apes from orangutans but before 
the divergence of humans, chimpanzees and gorillas, approximately 7 to 14 mya based on the 
estimated divergence time of primates (Goodman et al. 1998).  
To determine the functional status of the AMAC genes, we first examined all available 
AMAC copies for intact ORFs. Examination of the DNA sequences showed that the AMAC1 loci 
in both common chimpanzee and gorilla contained a premature stop codon in their ORF regions, 
located at amino acid position 29 and 32, respectively. Therefore, these two copies have lost their 
coding capacity and have become processed pseudogenes. The ORFs of all the other AMAC 
copies, including all four human copies, remained intact.  
Next, we examined the selective constraints on all AMAC copies using the maximum 
likelihood-based program PAML (Yang 1997). PAML estimates the non-synonymous (dN) and 
synonymous (dS) substitution rate ratios (ω=dN/dS) as measures of selective pressure, where the 
value of ω indicates the type of selection (<1, purifying; =1, neutral; >1, positive). Likelihood 
ratio tests can then be used to compare the different models of evolution. First, a maximum-
likelihood tree was constructed using all available AMAC ORF sequences (see methods), and ω 
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values were estimated according to a model of a single ω among branches of the tree (Model 0) 
and a model where ω is allowed to vary among branches (Model 1). The results showed that 
Model 1 fit the data significantly better than Model 0 (p<0.0001, Table 3.1), suggesting that 
different selective pressures are acting on the various AMAC copies within and between species. 
We then separated the branches of the tree into two groups, corresponding to the sequences 
predating the gene duplication events (Figure 3.4C, black branches) and sequences postdating 
duplication events (Figure 3.4C, bold blue branches) and estimated ω values for the two groups 
separately. The ω in the branches predating the duplications was estimated to be 0.13 
(significantly different from ω=1, p<0.0001), suggesting that the AMAC gene is under strong 
purifying selection in the species lacking duplicated copies. By contrast, the ω was estimated to 
be 1.24 (not significantly different from ω=1, p=0.25) in the species that possess multiple copies 
of AMAC. In addition, the comparison between Model 0 and Model 1 for branches after the 
duplications showed that ω values among branches are not significantly different (p=0.69). 
Together, these results indicate that the AMAC gene was under purifying selection in all the 
species prior to the duplication events and that, after the gene duplication events, all AMAC 
copies experienced a relaxation of selective constraints.  
These observations are in good agreement with the predictions of classical gene 
duplication theory (Ohno 1970; Prince and Pickett 2002), which suggests that the functional 
redundancy of newly duplicated genes will initially result in free evolution of all gene copies. 
The long-term evolutionary fate of the new gene copies includes loss of function (non-
functionalization), evolution of a new function (neo-functionalization) or maintenance of the 
duplicated copies for the original function (sub-functionalization). The stop codon present in 
different positions in the chimpanzee and gorilla AMAC1 copies shows the non-functionalization  
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Table 3.2: PAML analysis. 
 
  ω lnL np p  Significance 
All AMAC copies           
Model 0 (Single ω) 0.273 -3915 36     
Model 1 (Free ω) Varies -3812.7 69    
LRT Model 0 vs. Model 1     0.000 **  
AMACs Before Duplication           
Model 0 (Single ω) 0.13 -2866.7 15     
Model 0 (ω=1) 1 -3013 14    
Model 1 (Free ω) Varies -2831.4 27    
LRT Model 0 (Single ω) vs. Model 0 (ω= 1)     0.000 **  
LRT Model 0 (Single ω) vs. Model 1 (free ω)       0.000 ** 
Duplicated AMAC copies         
Model 0 (Single ω) 1.245 -2165.1 21     
Model 0 (ω=1) 1 -2165.7 20    
Model 1 (Free ω) Varies -2157.8 39    
LRT Model 0 (Single ω) vs. Model 0 (ω= 1)     0.251 No 
LRT Model 0 (Single ω) vs. Model 1 (free ω)       0.694 No 
Site Specific Models for duplicated copies        
            
Model 0 (NS site Model1_Neutral) p:   0.107  0.893 -2165.7 22    
  w:   1.000 1.000      
Model 0 (NS site Model2_PosSel) p:  0.824  0.000  0.176 -2154.9 24    
  w:   0.533  1.000  5.442      
LRT NS site M1_Neutral vs. M2_PosSel       0.000 **  
 
of these particular gene copies. Furthermore, we also analyzed the AMAC gene sequences for 
possible sites or domains that are (or were) under positive selection and developed new functions 
(neo-functionalization) (Tables 3.2 and 3.3). However, the paucity of functional studies on the 
human AMAC genes prevented detailed validation and comparisons of the potential functional 
role of candidate sites. 
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Table 3.3: Putative positive selection sites on AMAC genes. 
Site AA NEB BEB 
28 C 0.99* 0.95* 
88 R 0.99** 0.96* 
269 G 0.98* 0.94 
309 T 0.98* 0.9 
324 R 0.99* 0.95 
Putative positive selection sites were identified using PAML under Naive 
Empirical Bayes (NEB) analysis or Bayes Empirical Bayes (BEB) analysis.  
*: P>95%; **: P>99%. 
 
AMAC Expression Studies 
To further investigate the functional status of human AMAC gene duplicates, we examined the 
expression pattern of the four human AMAC gene copies. RT-PCR analysis was performed using 
poly(A)-selected RNA from human testis and placenta and oligonucleotide primers designed to 
match conserved regions in all four gene copies (supplemental data Figure A.2). We first 
amplified the target sequences from human genomic DNA (HeLa), cloned the PCR products and 
sequenced ~100 clones. Based on nucleotide substitutions specific for each AMAC gene 
duplicate, we determined the origin of each clone. Our results showed that all four gene copies 
were recovered in a comparable manner, showing that our approach amplifies the four human 
AMAC copies with similar efficiency (Figure 3.5B). Using the same primer set, RT-PCR 
generated a product with the expected size in both tissues (Figure 3.5A). We cloned the RT-PCR 
products and sequenced ~100 clones derived from each tissue (Figure 3.5B). Sequence analysis 
showed that AMAC1, AMAC1L2 and AMAC1L3 were expressed in testis while only AMAC1L2 
and AMAC1L3 were expressed in placenta. In both tissues, the SVA-transduced AMAC1L2 
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transduced AMAC gene duplicates are currently expressed in humans and that they may have 
differential tissue expression patterns. 
 
 
Figure 3.5. Expression analysis of AMAC gene duplicates in humans. (A) Agarose gel 
chromatograph of RT-PCR products derived from human testis (T) and placental (P) RNA 
templates. Negative controls with no reverse transcriptase (RT -) are on the left, a 100 bp marker 
(M) is in the middle and the sizes of the correct fragments are indicated. (B) Relative expression 
levels of four human AMAC gene duplicates in human testis and placenta. Human genomic 
DNA (HeLa) amplification is the control for uniform amplification of all gene duplicates. 
 
To further investigate the expression pattern of AMAC gene copies in human tissues, we 
searched the NCBI EST database for AMAC related transcripts. Consistent with the RT-PCR 
results, two of the SVA-transduced AMAC copies (AMAC1 and AMAC1L2) were recovered from 
the EST database and their full length cDNAs have already been sequenced (AK097473 and 
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AJ291677 for AMAC1 and AMAC1L2 respectively). Both mRNA sequences start downstream 
from the SVA elements, suggesting that their promoters have been duplicated along with the 
gene copies themselves. By contrast, the two transcripts contained unique 3’ UTR sequences 
specific to their new genomic locations. Thus, it appears that these two gene copies have 
acquired new downstream polyadenylation signals subsequent to their integration in the genome. 
Concluding Remarks 
Our results represent the first example in the primate lineage of gene duplications derived 
from SVA-mediated 3’ transduction. One factor that may increase the potency of SVA elements 
with regard to the generation of new genes is that, in addition to duplicating genes, SVA 
elements may also provide promoters for newly integrated gene duplicates. SVA elements 
contain a long terminal repeat (LTR) derived region that is used as promoter in endogenous 
retroviruses, and several studies have shown that LTRs in the genome can function as promoters 
for downstream genes (Dunn et al. 2003; Dunn et al. 2005). Therefore, the SVA LTR-derived 
tail region might function as an alternative promoter for genes involved in 3’ transduction events 
whenever the original gene-specific promoter was not transduced.  
Retrotransposon-mediated 3’ transduction represents a novel mechanism for entire gene 
duplication that can lead to the rapid generation of new gene families. Although the gene 
duplications by retrotransposon-mediated transduction reported here created intronless gene 
copies similar to duplications resulting from gene retrotransposition, there is one major 
difference between these two duplication mechanisms. Gene retrotransposition generally does 
not carry the promoter and regulatory region of the retrotransposed gene to its new location due 
to the process by which the gene is reverse transcribed into cDNA. Thus, the newly transposed 
gene must acquire new regulatory sequences to be functional. By contrast, retrotransposon-
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mediated 3’-transduction events not only duplicate whole genes, but can also duplicate promoter 
regions (as demonstrated by the AMAC gene duplicates). Consequently, duplications resulting 
from 3’-transduction retain their functional potential after inserting into their new genomic 
locations, allowing immediate release of the gene copies (the original as well as the duplicates) 
from selective constraints. 
Mobile elements are already known for creating genomic novelty in a variety of ways. 
For example, L1 elements provide the molecular machinery necessary for gene retrotransposition 
(Esnault et al. 2000; Wei et al. 2001) and new fusion genes can be generated during the process 
(Nisole et al. 2004; Sayah et al. 2004). DNA transposons can also mediate exon shuffling and 
gene duplication, as demonstrated by mutator-like elements and helitron-like elements in plants 
(Jiang et al. 2004; Morgante et al. 2005). Further, mobile elements themselves can serve as raw 
material for the generation of new functions by their incorporation into existing genes (Cordaux 
et al. 2006; Krull et al. 2005; Nekrutenko and Li 2001). By serving as a mechanism for gene 
duplication and generating new gene families, retrotransposon-mediated sequence transduction 
represents an important mechanism by which mobile elements impact their host genomes. 
Materials and Methods 
Genome Analysis 
The RepeatMasker annotations of the human genome reference sequence (hg17, May 
2004) were obtained from the UCSC Genome Bioinformatics Site (http://genome.ucsc.edu). The 
full-length SVA elements with 2000 bp flanking sequence on each side were exacted using a perl 
script and the TSDs were identified manually. SVA elements were considered as candidates for 
containing 3’ transduction sequence if they had (1) unambiguous TSDs (>6bp) and (2) more than 
30 bp sequence between the end of the SVA sequence and the poly(A) tail. The extra sequence 
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was then used for a sequence similarity BLAT search against the human genomic database. For 
genomic loci exhibiting >95% identity to the putative transduced sequence, 5 kb extra sequence 
was extracted on both ends of the locus and a locally installed RepeatMasker program was used 
to determine their repeat content. In some cases, segmental duplications may result in a similar 
pattern as the 3’ transduction. To remove such false positive hits, we further compared the 
sequence directly flanking the newly identified locus with the flanking sequence of the query 
locus. If the flanking sequences from both loci showed >90% sequence similarity for more than 2 
kb in length, the newly identified locus was excluded from the further analysis.  
PCR/RT-PCR and DNA Sequence Analysis 
The human population panel used in the polymorphism analysis were described 
previously (Wang et al. 2005). Other DNA samples used in this study included human genomic 
DNA (HeLa cell line ATCC CCL-2) and the following nonhuman primate species available as a 
primate phylogenetic panel PRP00001 from Coriell: DNA samples of Pan troglodytes (common 
chimpanzee), P. paniscus (bonobo or pygmy chimpanzee), Gorilla gorilla (western lowland 
gorilla), Pongo pygmaeus (orangutan) and Macaca mulatta (rhesus monkey). DNA samples of 
Hylobates syndactylus (siamang) was also purchased from Coriell (PR00721). DNA samples of 
Chlorocebus aethiops (green monkey) were isolated from a cell line ATCC CCL70.  
The primers and annealing temperatures for each locus are shown in Table A.4. For the 
AMAC gene analysis, AMAC gene related loci were amplified using PCR with different primates 
as templates using different primer sets and annealing temperatures (Table A.5).  
For RT-PCR, 1 μg of poly (A) selected RNA (Ambion) from human testis and placenta 
was used to perform the reverse transcription (RT) reaction using the Reverse Transcription 
System kit (Promega) with conserved primer 4(-) (5’-CAGATAGGAAGGCCACTGTTG-3’) 
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according to manufacturer’s protocol. After completion the volume of the RT reaction was 
brought to a final volume of 100 μl with nuclease free water. 10 μl of the RT reaction was used 
for PCR with conserved primer 1(+) (5’-ATTGCCCTGCTACTTAAACTGC-3’)/conserved 
primer 1(-) (5’-TGTAGTGTCCAGAGTCCAGGTC-3’) for 32 cycles at annealing temperature 
of 60 oC. PCR products were fractionated on a 1.5% low melting agarose gel and extracted with 
QIAquick Gel Extraction kit (QIAGEN).  
For sequencing analysis, individual RT-PCR/PCR products were cloned using the TOPO-
TA cloning kit (Invitrogen) and sequenced using chain termination sequencing on an ABI 3100 
Genetic Analyzer. All sequences were deposited in GenBank under accession numbers 
DQ482900-DQ482914.  
Evolutionary Analysis  
All available AMAC gene coding region homologous sequences were aligned using 
ClustalX (Thompson et al. 1997), followed by manual adjustments. Next, a maximum-likelihood 
tree were constructed under HKY85+G model using PAUP* (Swofford 2003) The resulting tree 
(supplemental data Figure A.3), was used for the dN/dS ratio analysis. 
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Mobile elements contribute greatly to the fluidity of the genomes by introducing genetic 
variation.  The SVA family has been relatively less well documented with respect to other 
retrotransposons residing within the human genome. In this study, I provided a comprehensive 
overview of the SVA elements found in the human genome for the first time.  
In chapter two, I first determined the SVA copy number in the human genome sequence. 
To examine the genomic distribution of SVA elements, I analyzed their distribution at the 
chromosomal level by comparing the observed number of the elements with the expected 
numbers based on size of the chromosomes. A chi-square analysis revealed that the two 
distributions are significantly different (χ2= 78.29, df = 23, p < 0.001), which indicated that SVA 
elements are non-randomly distributed in the human genome.  
Since the properties of the genomic sequence vary greatly among different human 
chromosomes, we further analyzed the distribution of SVA elements in relation to other genomic 
properties, such as G+C, gene and repeat contents of the SVA-flanking genomic regions. 
Genomic distribution analysis indicated that the SVA elements are enriched in G+C-rich regions 
but have no preferences for inter- or intra-genic regions.  
A phylogenetic analysis of the elements resulted in the recovery of six subfamilies, which 
were named SVA_A to SVA_F. Subfamily age estimates based upon nucleotide divergence 
indicate that subfamily SVA_A (13.56 Myrs) may have expanded contemporary to the 
divergence of the orangutan and the great apes (human, chimpanzee and gorilla) (12-15 million 
years ago (Mya)). The expansion of subfamilies SVA_B (11.56 Myrs), SVA_C (10.88 Myrs) 
and SVA_D (9.55 Myrs) may have predated the human, chimpanzee and gorilla divergence (~7 
Mya). The relatively young age of subfamilies SVA_E (3.46 Myrs) and SVA_F (3.18 Myrs) 
suggested these two subfamilies may have expanded after the human and chimpanzee divergence 
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(~4-6 mya).  In congruence with the age estimates, a survey of human genomic diversity 
associated with SVA_E and SVA_F subfamily members showed insertion polymorphism 
frequencies of 37.5% and 27.6%, respectively. 
Next, we use a median-joining network to examine the relationship among the 
subfamilies. Results from this analysis indicate that the older SVA subfamilies evolved in a 
single lineage: the SVA_A consensus has the highest sequence similarity to the counterpart of 
the ancestral HERV-K10 consensus. SVA_B differs from SVA_A by 9 substitutions and a 16 bp 
deletion is present at the 5’ end of the SVA_B consensus as compared to HERV-K10 sequence 
and the SVA_A consensus. This deletion is present in all other subfamily consensuses as well. 
SVA_C is derived from SVA_B, with SVA_D subsequently having evolved from SVA_C. 
Unlike the older subfamilies, the human-specific SVA_E and SVA_F were derived 
independently from a re-constructed ancestral sequence which is only one substitution different 
from SVA_D. In order to investigate the evolutionary history of the SVA elements, the copy 
number of SVA elements in different primate genomes was estimated by quantitative PCR 
(QPCR) using a pair of intra-SVA primers. Both the age estimates and the QPCR results showed 
that the full-length SVA element may have appeared in the Hominid lineage after the divergence 
of Hominids and Old World Monkeys. 
Both during and after integration into the genome, mobile elements frequently serve as 
substrates for creating genomic variation. In chapter three, I analyzed a specific mechanism (i.e. 
sequence transduction), by which SVA elements can impact their host genome. 
To examine the SVA-related transduction events, 1752 full-length SVA elements in the 
reference sequence of human genome were studied. In total, 143 SVA elements containing >6 bp 
TSD were identified with putative transduced sequences. Overall, 52,740 bp of genomic 
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sequence was duplicated by these SVA mediated transductions. The sizes of the transduced 
sequences ranged from 35 to 1853 bp in length, with an average of 340 bp. I also found that 3’ 
transduction is a common phenomenon among SVA members since all previously identified 
SVA families were involved in transduction.  
 One particularly interesting example of SVA-mediated 3’ transduction is the H17_76 
group. Detailed analysis of their transduced sequence at this locus resulted in the identification of 
the AMAC1 gene and AMAC1-like genes, which code for an enzyme that may be involved in the 
fatty acid synthesis process.  In total, there were four related loci in the human genome. The 
source locus (chr17_A) contained only the transduced sequence without the SVA element and 
the other three loci (chr17_B, chr18 and chr8) contained an SVA element along with the 
transduced sequence. Only the source locus has two exons separated by an intron, while the three 
SVA transduced loci contained intronless versions of AMAC1L3. All these results suggest that 
the intron was spliced out during the retrotransposition process, which provides further evidence 
for a genomic mechanism that created the three duplicated copies.  
Evolutionary analysis of the AMAC1 gene showed that the source locus existed in all 
examined primates and other mammals whose genomic sequence are available. On the other 
hand, the transduction events seem to have happened after the divergence of African apes from 
orangutans but before the divergence of humans, chimpanzees and gorillas, approximately 7 to 
14 Mya based on the estimated divergence time of primates.  I further examined the selective 
constraints on all AMAC copies using the maximum likelihood-based program PAML. The 
results are in good agreement with the predictions of classical gene duplication theory, which 
suggests that the functional redundancy of newly duplicated genes will initially result in free 
evolution of all gene copies. Lastly, I examined the expression pattern of the four human AMAC 
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gene copies by RT-PCR. The results showed that at least two SVA-transduced duplicates of the 
AMAC gene are currently expressed in humans and that they may have differential tissue 
expression patterns.  
In summary, by analyzing the structure of SVA subfamilies and the amplification 
mechanism during primate evolution, this study provides a good understanding of the biology of 
SVA elements within the primate order. This study also includes the first example of gene 
duplication derived from SVA-mediated 3’ transduction. This offers strong evidence that mobile 
elements can serve as raw material for the generation of new genetic functions by being 
incorporated into existing genes. 
The possibility that most of these hundred elements have fortuitously integrated right 
after a viable promoter is remote. So in the future study, I think the most important and 
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       ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
HERVK  --------------------------------------------------------------------------------------------------------------  
SVA_A  TCTCCCTCTGTT-----GCCGAGGCTGGACTGTACTGCCGTGATCTCGGCTCGCTGCAACCTCCCTGCCTCGGGCTCCCGTGATTCTCCTGCCTCGGCCTGCCGAGTGCC  
SVA_B  TCTCCCTCTGATGCCGAGCCGAGGCTGGACTGTACTGCCGCCATCTCGGCTCACTGCAACCTCCCTGCCT-----------GATTCTCCTGCCTCAGCCTGCCGAGTGCC  
SVA_C  TCTCCCTCTGATGCCGAGCCGAAGCTGGACTGTACTGCCGCCATCTCGGCTCACTGCAACCTCCCTGCCT-----------GATTCTCCTGCCTCAGCCTGCCGAGTGCC  
SVA_D  TCTCCCTCTGATGCCGAGCCGAAGCTGGACTGTACTGCTGCCATCTCGGCTCACTGCAACCTCCCTGCCT-----------GATTCTCCTGCCTCAGCCTGCCGAGTGCC  
SVA_E  TCTCCCTCTGATGCCGAGCCAAAGCTGGACGGTACTGCTGCCATCTCGGCTCACTGCAACCTCCCTGCCT-----------GATTCTCCTGCCTCAGCCTGCCGAGTGCC  
SVA_F  TCTCCCTCTCATGCGGAGCCGAAGCTGGACTGTACTGCTGCCATCTCGGCTCACTGCAACCTCCCTGCCT-----------GATTCTCCTGCCTCAGCCTGCCGAGTGCC  
        
       ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
HERVK  --------------------------------------------------------------------------------------------------------------  
SVA_A  TGGGATTGCAGGCACGCGCCGCCACGCCTGACTGGTTTTTGTATTTTT--GGTGGAGACGGGGTTTCGCCGTGTTGACCGGGCTGGTCTCCAGCTCCTGACCTCGAGTGA  
SVA_B  TGGGATTGCAGGCGCGCGCCGCCACGCCTGACTGGTTTTCGTATTTTTT-GGTGGAGACGGGGTTTCGCCGTGTTGGCCGGGCTGGTCTCCAGCTCCTGACCGCGAGTGA  
SVA_C  TGCGATTGCAGGCGCGCGCCGCCACGCCTGACTGGTTTTCGTATTTTTTTGGTGGAGACGGGGTTTCGCTGTGTTGGCCGGGCTGGTCTCCAGCTCCTAACCGCGAGTGA  
SVA_D  TGCGATTGCAGGCGCGCGCCGCCACGCCTGACTGGTTTTCGTATTTTTTTGGTGGAGACGGGGTTTCGCTGTGTTGGCCGGGCTGGTCTCCAGCTCCTAACCGCGAGTGA  
SVA_E  TGCGATTGCAGGCGCGCGCCGCCACGCCTGACTGGTTTTCGTTTTTTTTTGGTGGAGACGGGGTTTCGCTGTGTTGGCCGGGCTGGTCTCCAGCTCCTAACCGCGAGTGA  
SVA_F  TGCGATTGCAGGCACGCGCCGCCACGCCTGACTGGTTTT-----------GGTGGAGACGGGGTTTCGCTGTGTTGGCCGGGCCGGTCTCCAGCCCCTAACCGCGAGTGA  
         
       ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
HERVK  --------------------------------------------------------------------------------------------------------------  
SVA_A  TCTGCCCGCCTCGGCCTCCCGAGGTGCTGGGATTGCAGACGGAGTCTCGCTCACTCAATGCTCAATGTTGCCCAGGCTGGAGTGCAGTGGCGTGATCTCGGCTCGCTACA  
SVA_B  TCTGCCAGCCTCGGCCTCCCGAGGTGCCGGGATTGCAGACGGAGTCTCGCTCACTCAGTGCTCAATGTTGCCCAGGCTGGAGTGCAGTGGCGTGATCTCGGCTCGCTACA  
SVA_C  TCTGCCAGCCTCGGCCTCCCGAGGTGCCGGGATTGCAGACGGAGTCTCGTTCACTCAGTGCTCAATGTTGCCCAGGCTGGAGTGCAGTGGCGTGATCTCGGCTCGCTACA  
SVA_D  TCCGCCAGCCTCGGCCTCCCGAGGTGCCGGGATTGCAGACGGAGTCTCGTTCACTCAGTGCTCAATGGTGCCCAGGCTGGAGTGCAGTGGCGTGATCTCGGCTCGCTACA  
SVA_E  TCCGCCAGCCTCGGCCTCCCGAGGTGCCGGGATTGCAGACGGAGTCTCGTTCACTCAGTGCTCAATGGTGCCCAGGCTGGAGTGCAGTGGCGTGATCTCGGCTCGCTACA  
SVA_F  TCCGCCAACCTCGGCCTCCCGAGGTGCCGGGATTGCAGACGGAGTCTCGTTCACTCAGTGCTCAATGGTGCCCAGGCTGGAGTGCAGTGGCGTGATCTCGGCTCACTACA  
            
       ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
HERVK  -------------------------------------------ACAGCTCCGAAGAGACAGCGACCATCGAGAACGGGCCATGATGACGATGGCGGTTTTGTCGAAAAGA  
SVA_A  ACCTCCACCTCCCAGCCGCCTGCCTTGGCCTCCCAAAGTGCTAACAGCTCCGAAGAGACAGCGACCATCGAGAACGGGCCATGATGACGATGGCGGTTTTGTCGAAAAGA  
SVA_B  ACCTCCACCTCCCAGCCGCCTGCCTTGGCCTCCCAAAGTGCCGACAGCT----------------CATTGAGAACGGGCCATGATGACGATGGCGGTTTTGTCGAATAGA  
SVA_C  ACCTCCACCTCCCAGCCGCCTGCCTTGGCCTCCCAAAGTGCCGACAGCT----------------CATTGAGAACGGGCCATGATGACGATGGCGGTTTTGTCGAATAGA  
SVA_D  ACCTCCACCTCCCAGCCGCCTGCCTTGGCCTCCCAAAGTGCCGACAGCT----------------CATTGAGAACGGGCCATGATGACAATGGCGGTTTTGTGGAATAGA  
SVA_E  ACC---ACCTCCCAGCCGCCTGCCTTGGCCTCCCAAAGAGCCGGCGGCT----------------CATTGGGGATGGGCCATGATGACAATGGCGGTTTTGTGGAATAGA  
SVA_F  ACCTACACCTCCCAGCCGCCTGCCTTGGCCTCCCAAAGTGCCGACAGCT----------------CATTGAGAACGGGCCAGGATGACAATGGCGGCTTTGTGGAATAGA  
 
       ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
HERVK  AAAGGGGGAAATGTGGGGAAAAGCAAGAGAGATCAAATTGTTACTGTGTCTGTGTAGAAAGAAGTAGACATAGGAGAC--TCCATTTTGTTATGTGCTAAGAAAAATTCT  
SVA_A  AAAGGGGGAAATGTGGGGAAAAGAAAGAGAGATCAGATTGTTACTGTGTCTGTGTAGAAAGAAGTAGACATAGGAGAC--TCCATTTTGTTCTGTACTAAGAAAAATTCT  
SVA_B  AAAGGGGGAAATGTGGGGAAAAGAAAGAGAGATCAGATTGTTACTGTGTCTGTGTAGAAAGAAGTAGACATAGGAGAC--TCCATTTTGTTCTGTACTAAGAAAAATTCT  
SVA_C  AAAGGGGGAAATGTGGGGAAAAGATAGAGAAATCAGATTGTTGCTGTGTCTGTGTAGAAAGAAGTAGACATAGGAGAC--TCCATTTTGTTCTGTACTAAGAAAAATTCT  
SVA_D  AAGGGGGGAAAGGTGGGGAAAAGATTGAGAAATCGGATGGTTGCCGTGTCTGTGTAGAAAGAAGTAGACATGGGAGACTTTTCATTTTGTTCTGTACTAAGAAAAATTCT  
SVA_E  AAGGCGGGAAGGGTGGGGAAAAAATTGAGAAATCGGATGGTTGCCGGGTCTGTGTGGATAGAAGTAGACATGGGAGACTTTTCATTTTGTTCTGTACTAAGAAAAATTCT  
SVA_F  AAGGCGGGAAAGGTGGGGAAAAGATTGAGAAATCGGATGGTTGCCGTGTCTGTGTAGAAAGAAGTAGACATGGGAGACTTTTCATTTTGTTCTGCACTAAGAAAAATTCC  
          
       ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
HERVK  TCTGCCTTGAGATTCTGTTAATCTATGACCTTACCCCCAACCCCGTGCTCTCTGAAACATGTGCTGTGTCAACTCAGGGTTGAATGGATTAAGGGCGGTGCAGGATGTGC  
SVA_A  TCTGCCTTGGGATGCTGTTAATCTATAACCTTACCCCCAACCCCGTGCTCTCTGAAACATGTGCTGTGTCAACTCAGGGTTAAATGGATTAAGGGCGGTGCAAGATGTGC  
SVA_B  TCTGCCTTGGGATGCTGTTAATCTATAACCTTACCCCCAACCCCGTGCTCTCTGAAACATGTGCTGTGTCCACTCAGGGTTAAATGGATTAAGGGCGGTGCAAGATGTGC  
SVA_C  TCTGCCTTGGGATGCTGTTGATCTATGACCTTACCCCCAACCCGGTGCTCTCTGAAACATGTGCTGTGTCCACTCAGGGTTAAATGGATTAAGGGCGGTGCAAGATGTGC  
SVA_D  TCTGCCTTGGGATCCTGTTGATCTGTGACCTTACCCCCAACCCTGTGCTCTCTGAAACATGTGCTGTGTCCACTCAGGGTTAAATGGATTAAGGGCGGTGCAAGATGTGC  
SVA_E  TCTGCCTTGGGATCCTGTTGATCTGTGACCTTATCCCCAACCCTGTGCTCTCTGAAACATGTGCTGTGTCCACTCAGGGTTAAATGGATTAAGGGCGGTGCAAGATGTGC  
SVA_F  TCTGCCTTGGGATCCTGTTGATCTGTGACCTTACCCCCAACCCTGTGCTCTCTGAAACATGTGCTGTGTCCACTCAGGGTTAAATGGATTAAGGGCGGTGCAAGATGTGC  
       
       ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
HERVK  TTTGTTAAACAGATGCTTGAAGGCAGCATGCTCCTTAAGAGTCATCACCACTCCCTAATCTCAAGTACCCAGGGACACAAAAACTGCAGAAGGCCGCAGGGACCTCTGCC  
SVA_A  TTTGTTAAACAGATGCTTGAAGGCAGCATGCTCGTTAAGAGTCATCACCACTCCCTAATCTCAAGTACCCAGGGACACAAACACTGCGGAAGGCCGCAGGGACCTCTGCC  
SVA_B  TTTGTTAAACAGATGCTTGAAGGCAGCATGCTCGTTAAGAGTCATCACCACTCCCTAATCTCAAGTACCCAGGGACACAAACACTGCGGAAGGCCGCAGGGTCCTCTGCC  
SVA_C  TTTGTTAAACAGATGCTTGAAGGCAGCATGCTCGTTAAGAGTCATCACCACTCCCTAATCTCAAGTACCCAGGGACACAAACACTGCGGAAGGCCGCAGGGTCCTCTGCC  
SVA_D  TTTGTTAAACAGATGCTTGAAGGCAGCATGCTCGTTAAGAGTCATCACCACTCCCTAATCTCAAGTACCCAGGGACACAAACACTGCGGAAGGCCGCAGGGTCCTCTGCC  
SVA_E  TTTGTTAAACAGATGCTTGAAGGCAGCATGCTCGTTAAGAGTCATCACCACTCCCTAATCTTAAGTACCCAGGGACACAAACACTGCGGAAGGCCGCAGGGTCCTCTGCC  
SVA_F  TTTGTTAAACAGATGCTTGAAGGCAGCATGCTCGTTAAGAGTCATCACCAATCCCTAATCTCAAGTAATCAGGGACACAAACACTGCGGAAGGCCGCAGGGTCCTCTGCC  
0           
       ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
HERVK  TAGGAAAGCCAGAGACCTTTGTTCACGTGTTTGTCTGCTGACCCTCTCCCCACAATTGTCTTGTGACCCTGACACATCCCCCTCTTTGAGAAACACCCACAGATGATCAA  
SVA_A  TAGGAAAACCAGAGACCTTTGTTCACGTGTTTATCTGCTGACCTTCTCTCCACTATTATCCTATGACCCTGCCACATCCCCCTCTCCGAGAAACACCCAAGAATGATCAA  
SVA_B  TAGGAAAACCAGAGACCTTTGTTCACATGTTTATCTGCTGACCTTCCCTCCACTATTGTCCTATGACCCTGCCAAATCCCCCTCTCCGAGAAACACCCAAGAATGATCAA  
SVA_C  TAGGAAAACCAGAGACCTTTGTTCACTTGTTTATCTGCTGACCTTCCCTCCACTATTGTCCTATGACCCTGCCAAATCCCCCTCTGCGAGAAACACCCAAGAATGATCAA  
SVA_D  TAGGAAAACCAGAGACCTTTGTTCACTTGTTTATCTGCTGACCTTCCCTCCACTATTGTCCTATGACCCTGCCAAATCCCCCTCTGCGAGAAACACCCAAGAATGATCAA  
SVA_E  TAGGAAAACCAGAGACCTTTGTTCACTTGTTTATCTGCTGACCTTCCCTCCACTATTGTCCTATGACCCTGCCAAATCCCCCTCTGCGAGAAACACCCAAGAATGATCAA  
SVA_F  TAGGAAAACCAGAGACCTTTGTTCACTTGTTTATCTGCTGACCTTCCCTCCACTATTGTCCCATGACCCTGCCAAATCCCCCTCTGTGAGAAACACCCAAGAATTATCAA  
 
       ....|....| 
HERVK  TAAATACTAA  
SVA_A  TAAATACTAA  
SVA_B  TAAATACTAA  
SVA_C  TAAAAAAAAA  
SVA_D  TAAAAAAAAA  
SVA_E  TAAAAAAAAA  
SVA_F  TAAAAAAAAT  
 
Figure A.1: Multiple alignments of human SVA subfamily consensuses along with the 




                  10        20        30        40        50        60        70        80                
         ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
AMAC1    ATGGCTGGCAGTCACCCCTATTTCAACCAGCCTGACTCCACACACCCATCGCCGCCCTCCGCTCCACCCAGCCTCCGCTG  
AMAC1L1  ....................C.......T...............................A...............A...  
AMAC1L2  ....................C.......T...................................................  
AMAC1L3  ....................C..G....C...................................................  
 
                  90       100       110       120       130       140       150       160         
         ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
AMAC1    GTACCAACGCTGCCAGCCCTCTGATGCCACCAGTGGCCTGCTGGTGGCCCTGCTGGGTGGGGGCCTGCCTGCTGGCTTCG  
AMAC1L1  .C....G.........................A...............................................  
AMAC1L2  .C....G................G........A...............................................  
AMAC1L3  .C....GT........................A...............................................  
 
                 170       180       190       200       210       220       230       240        
         ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
AMAC1    TGGGCCCCCTTTCTCGTATGGCTTACCAGGCTTCCAACCTGCCCTCGCTGGAGCTGCTCATCTGGCGATGCCTCTTCCAC  
AMAC1L1  ........................................................G.......T...............  
AMAC1L2  ..............................G.................................T...............  
AMAC1L3  ...............A................................................T...............  
 
                 250       260       270       280       290       300       310       320        
         ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
AMAC1    CTCCCTATTGCCCTGCTACTTAAACTGCGTGGCGACCCCCTTCTGGGAACTCCTGACATCCGAAGCCGGGCCTTCTTCTG  
AMAC1L1  ................................................C..............G....CA...G......  
AMAC1L2  ................................................C..............G..T......G......  
AMAC1L3  ................................................C..............G.........A.....A  
 
                 330       340       350       360       370       380       390       400        
         ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
AMAC1    TGCCCTGCTCAACATCCTCAGCATTGGATGTGCCTACAGTGCGGTTCAGGTGGTGCCCGCTGGCAACGCTGCCACTGTTC  
AMAC1L1  .............G......A...............T.....................A.......T.............  
AMAC1L2  .............G............................A.....................................  
AMAC1L3  .............G..................................................................  
 
                 410       420       430       440       450       460       470       480        
         ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
AMAC1    GCAAAGGTTCTTCCACCGTCTGCTCCGCCGTCCTCACTCTCTGCCTTGAGAGCCAGGGTCTCAGTGGCTACGACTGGTGT  
AMAC1L1  .....CA......................A.......C...................T......................  
AMAC1L2  ...................A........T........C........................G..........G......  
AMAC1L3  .....................................C..........................................  
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                 490       500       510       520       530       540       550       560        
         ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
AMAC1    GGACTGTTGGGCTGCATCCTAGGACTAATCATCATTGTGGGACCTGGACTCTGGACACTACAGGAGGGGACCACGGGTGT  
AMAC1L1  ............A................A..................................................  
AMAC1L2  ............A.......................C.....................................A.....  
AMAC1L3  ............A.........................................................T.........  
 
                 570       580       590       600       610       620       630       640        
         ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
AMAC1    CTACACCGCCCTGGGCTATGTGGAGGCTTTCCTGGGAGGCCTGGCGCTGTCCCTGAGGCTTCTGGTCTATCGTTCTCTGC  
AMAC1L1  ........G.............C................A...............G.......C................  
AMAC1L2  .......A..............C................................G........................  
AMAC1L3  ....................G.C........G.......A...............G........................  
 
                 650       660       670       680       690       700       710       720        
         ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
AMAC1    ACTTTCCCCCCTGCCTCCCAACAGTGGCCTTCCTATCTGGCTTGGTGGGGCTGCTGGGCTCTGTGCCAGGCCTCTTTGTG  
AMAC1L1  ........T.......................................................................  
AMAC1L2  ........T...................................................G...................  
AMAC1L3  ........T.......................................................................  
 
                 730       740       750       760       770       780       790       800        
         ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
AMAC1    CTGCAGGCCCCCGTGTTGCCCAGTGACCTCCTGAGTTGGAGTTGTGTGGGGGCAGTGGGGATCCTCGCCTTGGTCTCCTT  
AMAC1L1  ......T...........................................................A.............  
AMAC1L2  ......A................................................A........................  
AMAC1L3  ......C...................T....C................................................  
 
                 810       820       830       840       850       860       870       880        
         ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
AMAC1    CACATGTGTGGGCTATGCGGTCACCAAGGCCCACCCTGCCCTGGTGTGCGCTGTCCTACATTCCGAGGTGGTTGTGGCCC  
AMAC1L1  ................................................T........G..............GA......  
AMAC1L2  .........................................................G......................  
AMAC1L3  ..........A..............................................G..............G.......  
 
                 890       900       910       920       930       940       950       960        
         ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
AMAC1    TTATACTGCAGTATTATATGCTCCATGAGACTGTGGCACCTTCTGACATCGTGGCGGCAGGGGTTGTGCTGGGCAGCATT  
AMAC1L1  ...............T..................................A...G.........................  
AMAC1L2  .......................................T..........A...G.........................  




                 970       980       990       1000      1010          
         ....|....|....|....|....|....|....|....|....|....|....|.. 
AMAC1    GCCATCATTACAGCCCAGAACCTCAGCTGTGAGAGGACAGGGAGGGTGGAGGAGTGA  
AMAC1L1  ................G........T.................A.............  
AMAC1L2  ................G..........................A.............  
AMAC1L3  ........C......TG...................GA.....A.............  
 
 
Figure A.2: Multiple sequence alignment of human AMAC coding regions. Sequence of the coding region of human AMAC1 is 
shown at the top and the sequence of other AMAC copies are shown below. Dots represent the same nucleotides as the AMAC1 















































Figure A.3: Phylogeny of the AMAC coding regions used in PAML analysis. Human AMAC 














Table A.1: Insertion allele frequencies, heterozygosities and genotypes of the SVA insertion polymorphisms. 
 
  African American Asian European South American   
  Genotypes     Genotypes     Genotypes     Genotypes       
Elements +/+ +/- -/- f Het +/+ +/- -/- f Het +/+ +/- -/- f Het +/+ +/- -/- f Het Avg Het  
H1_F_95 19 1 0 0.98 0.05 20 0 0 1 0 20 0 0 1 0 20 0 0 1 0 0.01 
H1_F_127 18 2 0 0.95 0.1 20 0 0 1 0 20 0 0 1 0 20 0 0 1 0 0.03 
H1_F_163 4 2 14 0.25 0.38 3 6 8 0.35 0.47 9 9 2 0.68 0.45 7 10 3 0.6 0.49 0.33 
H2_F_9 11 9 0 0.78 0.36 2 18 0 0.55 0.51 12 8 0 0.8 0.33 14 6 0 0.85 0.26 0.3 
H2_F_56 1 8 11 0.25 0.38 6 12 2 0.6 0.49 3 5 12 0.28 0.41 2 4 14 0.2 0.33 0.32 
H2_F_76 6 10 4 0.55 0.51 10 6 4 0.65 0.47 11 8 1 0.75 0.38 13 6 1 0.8 0.33 0.34 
H2_F_129 3 5 9 0.32 0.45 4 12 4 0.5 0.51 3 4 12 0.26 0.4 2 6 11 0.26 0.4 0.34 
H5_F_9 20 0 0 1 0 19 1 0 0.98 0.05 19 1 0 0.98 0.05 18 2 0 0.95 0.1 0.03 
H5_F_171 0 17 3 0.43 0.5 6 9 5 0.53 0.51 6 11 3 0.58 0.5 7 8 5 0.55 0.5 0.38 
H6_F_74 16 0 0 1 0 20 0 0 1 0 19 0 0 1 0 18 0 0 1 0 0 
H6_F_172 2 9 9 0.33 0.45 0 1 19 0.03 0.05 1 8 11 0.25 0.38 0 2 18 0.05 0.1 0.22 
H7_F_22 3 11 6 0.43 0.5 15 5 0 0.88 0.22 12 8 0 0.8 0.33 5 10 5 0.5 0.51 0.26 
H7_F_35 10 1 2 0.81 0.32 13 2 0 0.93 0.13 3 6 7 0.38 0.48 9 3 5 0.62 0.49 0.23 
H7_F_61 0 10 10 0.25 0.38 0 6 14 0.15 0.26 2 10 8 0.35 0.47 4 9 7 0.43 0.5 0.28 
H7_F_148 3 11 6 0.43 0.5 0 0 20 0 0 4 7 9 0.38 0.48 1 8 11 0.25 0.38 0.25 
H8_F_89 20 0 0 1 0 20 0 0 1 0 19 0 0 1 0 20 0 0 1 0 0 
H1_E_43 0 4 16 0.1 0.18 0 0 20 0 0 0 0 20 0 0 0 1 19 0.03 0.05 0.05 
H1_E_89 5 15 0 0.63 0.48 10 10 0 0.75 0.38 3 17 0 0.58 0.5 11 9 0 0.78 0.36 0.34 
H1_E_271 2 3 15 0.18 0.3 3 13 4 0.48 0.51 1 12 7 0.35 0.47 1 11 8 0.33 0.45 0.32 
H2_E_239 0 2 17 0.05 0.1 0 0 20 0 0 2 2 16 0.15 0.26 0 0 19 0 0 0.09 
H2_E_245 0 3 17 0.08 0.14 6 11 3 0.58 0.5 1 5 6 0.29 0.43 2 6 7 0.33 0.46 0.27 
H2_E_256 0 2 18 0.05 0.1 0 2 18 0.05 0.1 1 8 11 0.25 0.38 0 6 14 0.15 0.26 0.15 
H5_E_27 20 0 0 1 0 20 0 0 1 0 20 0 0 1 0 19 1 0 0.98 0.05 0 
H5_E_128 0 17 3 0.43 0.5 0 9 11 0.23 0.36 0 12 6 0.33 0.46 3 4 13 0.25 0.38 0.33 
H6_E_1 2 13 5 0.43 0.5 0 1 19 0.03 0.05 1 7 12 0.23 0.36 0 5 15 0.13 0.22 0.23 
H6_E_146 8 11 1 0.68 0.45 16 4 0 0.9 0.18 9 10 1 0.7 0.43 15 3 2 0.83 0.3 0.27 
H7_E_5 1 14 5 0.4 0.49 2 7 9 0.31 0.44 1 6 9 0.25 0.39 2 9 8 0.34 0.46 0.33 






(Table A.1 cont.) 
H7_E_82 3 13 3 0.5 0.51 0 12 8 0.3 0.43 0 20 0 0.5 0.51 0 15 5 0.38 0.48 0.36 
H7_E_171 0 20 0 0.5 0.51 4 16 0 0.6 0.49 4 16 0 0.6 0.49 4 16 0 0.6 0.49 0.37 
H8_E_35 19 1 0 0.98 0.05 20 0 0 1 0 20 0 0 1 0 20 0 0 1 0 0.01 
H8_E_45 20 0 0 1 0 19 1 0 0.98 0.05 20 0 0 1 0 20 0 0 1 0 0.01 
H14_E_66 11 7 2 0.93 0.41 6 11 3 0.58 0.5 0 4 16 0.1 0.18 2 9 9 0.33 0.45 0.27 
H20_E_91 18 2 0 0.95 0.1 20 0 0 1 0 19 1 0 0.98 0.05 19 1 0 0.98 0.05 0.04 
 
 
Table A.2: PCR primers, annealing temperature, amplicon sizes of human specific SVA elements. 
 
Name Chr 5' Primer Sequence (5'-3') 3' Primer Sequence (5'-3') Annealing Product Sizes 
    Temp Empty Filled 
H1_E_8IN 1 TCTGCCTAGGAAAACCAGAGAC GGCTGACTTAGAGGACAAGTGC 60 - 395 
H1_E_8OUT 1 ATTACTGTGAGCAGGACCAACC GGCTGACTTAGAGGACAAGTGC 60 345 3086 
H1_E_27IN 1 TGTGTCCACTCAGGGTTAAATG TGTCACCTTCCCTGATACCTCT 60 - 407 
H1_E_27OUT 1 GCCAACACTGCTTTTTCATCTT TGTCACCTTCCCTGATACCTCT 60 236 2786 
H1_E_43IN 1 AGTACCCAGGGACACAAACACT TTCATCGTTTCCTGGAATTCTT 60 - 408 
H1_E_43OUT 1 AGCCATAGCCAATGATCAAGTT TTCATCGTTTCCTGGAATTCTT 60 301 3121 
H1_E_50IN 1 TGTGTCCACTCAGGGTTAAATG CAAGAAGGGCAGAGCCTATCTA 60 - 386 
H1_E_50OUT 1 GAAATGTCCTGCAGTTGTTTGA CAAGAAGGGCAGAGCCTATCTA 60 396 2566 
H1_E_89IN 1 AACCCTGTGCTCTCTGAAACAT AGCTCATGAGGCACCATTTATT 60 - 439 
H1_E_89OUT 1 GGAGCTGCTAACGCTAATGAAC AGCTCATGAGGCACCATTTATT 60 276 1187 
H1_E_101IN 1 ACCTTCCCTCCACTATTGTCCT TGCATAAGAATCACCCAGAAAC 60 - 469 
H1_E_101OUT 1 TTTTGCTAAAGGCTCTGAGACA TGCATAAGAATCACCCAGAAAC 60 828 3448 
H1_E_115IN 1 GGATCCTGTTGATCTGTGACCT CAACATTTCACATTTGTGGATCA 60 - 396 
H1_E_115OUT 1 TCCATTATTTTTCGGTTTGTCC CAACATTTCACATTTGTGGATCA 60 303 2812 
H1_E_124IN 1 TGTGTCCACTCAGGGTTAAATG GAAATGCCAAATTCCCTCTGTA 60 - 639 
H1_E_124OUT 1 TCCAAGACAATCTTCTAAACCTCA GAAATGCCAAATTCCCTCTGTA 60 752 2959 





(Table A.2 cont.) 
H1_E_189OUT 1 CATGAGAGAAAGCTGATGCAAG CTCTGCCATCTTTGGTGTATCA 60 189 2659 
H1_E_271IN 1 TGAGAGTCATCACCACTCCCTA GGGCAAGTAAGCCAGTATTGAA 60 - 425 
H1_E_271OUT 1 GTTCATTCACTGGAAGCACAA GGGCAAGTAAGCCAGTATTGAA 60 709 2115 
H1_E_302IN 1 TCTGAAACATGTGTTGTGTCCA GGCAGAACTAACAAAGCAGACA 60 - 778 
H1_E_302OUT 1 CCGTATGATATTCCATCGTGTG GGCAGAACTAACAAAGCAGACA 60 805 2374 
H2_E_1IN 2 TGTGTCCACTCAGGGTTAAATG ATGAGTCTTTTGCAGGCATTCT 60 - 349 
H2_E_1OUT 2 GGTTGTTGTGACTTGGCTATCA ATGAGTCTTTTGCAGGCATTCT 60 360 1837 
H2_E_13IN 2 TGTGTCCACTCAGGGTTAAATG TTAAATGGCTTaCAGCgAACTG 60 - 500 
H2_E_13OUT 2 ACTTCCCTGAAGTTTGTTGGTT TTAAATGGCTTaCAGCgAACTG 60 299 1269 
H2_E_33IN 2 TGTGTCCACTCAGGGTTAAATG GAGGTATTGGGGTGAATGTTTG 60 - 425 
H2_E_33OUT 2 GGTCTCAGCCATTAATTTGAGC GAGGTATTGGGGTGAATGTTTG 60 426 2760 
H2_E_39IN 2 TGTGTCCACTCAGGGTTAAATG GCAGGTGGCAGTCTTAGTACCT 60 - 455 
H2_E_39OUT 2 TCCAAATCAAAGAGGACTGGAT GCAGGTGGCAGTCTTAGTACCT 60 319 2259 
H2_E_140IN 2 TGTGTCCACTCAGGGTTAAATG AACCCAATGTACATCCAAGACC 60 - 689 
H2_E_140OUT 2 TTCCAAATGTCAGGGTAACAGA AACCCAATGTACATCCAAGACC 60 673 2509 
H2_E_219IN 2 TGTGTCCACTCAGGGTTAAATG TAGGCCCTGTTGTCAATAATCC 60 - 392 
H2_E_219OUT 2 TGTGAAACCATGGTCAGTAAGC TAGGCCCTGTTGTCAATAATCC 60 183 2423 
H2_E_239IN 2 TGTGTCCACTCAGGGTTAAATG CATGCTTTTTGCCTTAATTTCA 60 - 748 
H2_E_239OUT 2 ATACAGAAGGTACTGGGGAAGC CATGCTTTTTGCCTTAATTTCA 60 627 3027 
H2_E_245IN 2 TGTGTCCACTCAGGGTTAAATG AGGGAAGGTGTGGAAAAAGATT 60 - 768 
H2_E_245OUT 2 AAACCAACAACTTTGCATAGGG AGGGAAGGTGTGGAAAAAGATT 60 551 3109 
H2_E_256IN 2 TGTGTCCACTCAGGGTTAAATG CTCTTTTGTCCTGGCCTGTTAC 60 - 330 
H2_E_256OUT 2 AATGTGAAGGTCTCCACTGACC CTCTTTTGTCCTGGCCTGTTAC 60 155 2645 
H2_E_261IN 2 TCTGCCTAGGAAAACCAGAGAC TGGCCTGGAACAAACATACATA 60 - 669 
H2_E_261OUT 2 CCAGAAAACAATGGAGCAAAAT TGGCCTGGAACAAACATACATA 60 616 2123 
H5_E_22IN 5 TGTGTCCACTCAGGGTTAAATG GAAGACAGGGtGGAAGAAAATG 55 - 405 
H5_E_22OUT 5 TGCCAGTCTCTTCGTGAAACTA GAAGACAGGGtGGAAGAAAATG 55 430 1873 




(Table A.2 cont.) 
H5_E_27OUT 5 AATTGAGGTTAGATAGACCTGTTCA GCATGAGGCAAACTCTCTTTTT 55 180 3075 
H5_E_128IN 5 TGTGTCCACTCAGGGTTAAATG GCTGAGAGTCTCCTCCCTGTTA 55 - 412 
H5_E_128OUT 5 CCTTGTAGTTTGTTGGCATGAA GCTGAGAGTCTCCTCCCTGTTA 55 470 1795 
H6_E_1IN 6 AGTACCCAGGGACACAAACACT ATTCAAATCCCTCTGCAAAGAA 55 - 553 
H6_E_1OUT 6 TCCGGTAAGCTTCATACCAGTT ATTCAAATCCCTCTGCAAAGAA 55 640 2572 
H6_E_146IN 6 TGCTCTCTGAAACATGTGCTGT TTTCTCCCTTCCCATTTTTGTA 55 - 419 
H6_E_146OUT 6 TTAACAGCACGTAGCACAGTGA TTTCTCCCTTCCCATTTTTGTA 55 580 3196 
H6_E_157IN 6 TGTGTCCACTCAGGGTTAAATG GAAATGGACTGTGGATTGTGAA 55 - 438 
H6_E_157OUT 6 CCAACTCAGTAGATGGCTCCTC AGGTTCCCcTCTGTTAAATGCT 55 580 2269 
H7_E_5IN 7 AGTACCCAGGGACACAAACACT TCATTTCCATCAGGtAGGCTTT 55 - 558 
H7_E_5OUT 7 AATTTTGAAACTGGGTGGTCAG TCATTTCCATCAGGtAGGCTTT 55 510 3099 
H7_E_27IN 7 AGTACCCAGGGACACAAACACT GCCTATGCTGATACCACTCCTC 55 - 420 
H7_E_27OUT 7 GTGCACAGAAGGATACATGGAA GCCTATGCTGATACCACTCCTC 55 480 2579 
H7_E_31IN 7 TCTGCCTAGGAAAACCAGAGAC CATTGGGAGAGGGGACATTTAT 55 - 490 
H7_E_31OUT 7 TTGCCAATTTCTAACCCTGACT CATGGCAATCACCTCCTTTAT 55 180 3211 
H7_E_45IN 7 CTGTAGGTTCTGATCGCCCTAT CCAGAGAGAATTTGGCAAGACT 55 - 508 
H7_E_45OUT 7 CATGCCAGCTCAGCTATGTAAG CCAGAGAGAATTTGGCAAGACT 55 700 2518 
H7_E_82IN 7 AAGTACCCAGGGACACAAACAC ACAGAGGATTGGCGTAATGACT 55 - 783 
H7_E_82OUT 7 TTCTGGAAATACCATCTTTGGA ACAGAGGATTGGCGTAATGACT 55 800 3250 
H7_E_156IN 7 TGTGTCCACTCAGGGTTAAATG GCCTTCCCATCATATTTGTCAC 55 - 431 
H7_E_156OUT 7 CCCTCTGAAGCTCACAGAAATC GCCTTCCCATCATATTTGTCAC 55 750 2998 
H7_E_171IN 7 TGAACACTCAGGGTTAAATGGA TTGATTTCtTGCAGCAATGTTC 55 - 409 
H7_E_171OUT 7 GAATAGAAGGGTGCTTCCTCAA TTGATTTCtTGCAGCAATGTTC 55 500 3112 
H8_E_15IN 8 TGTGTCCACTCAGGGTTAAATG AGGTGGGGGAGGTGTATAATAA 55 - 477 
H8_E_15OUT 8 TGCTTTTTACCCATATTTCCACA AGGTGGGGGAGGTGTATAATAA 55 190 2553 
H8_E_17IN 8 AGTACCCAGGGACACAAACACT AAGGGAAATATTGGGAGAAGGA 55 - 531 
H8_E_17OUT 8 TGGCTGCAGGGACTTAATTTAT AAGGGAAATATTGGGAGAAGGA 55 580 2602 




(Table A.2 cont.) 
H8_E_35OUT 8 TTGTGTCCTCTTCTGCTAACGA CAAGAGCGATTGAAGGTTTTCT 55 350 2999 
H8_E_45IN 8 TGTGTCCACTCAGGGTTAAATG CAGTAAAAGAGAGCGAATGCAG 55 - 480 
H8_E_45OUT 8 CCACAACTCTGGCTTAATGTGA CAGTAAAAGAGAGCGAATGCAG 55 710 2998 
H8_E_94IN 8 AGTACCCAGGGACACAAACACT TGCTTCATCAGTGAGATTGACA 55 - 487 
H8_E_94OUT 8 GCTGAAAACATCTCAAGTCACG CCATTGTCTCTTGGCCTATGTT 55 260 2393 
H8_E_103IN 8 GGTGCAAGATGTGCTTTGTTA CCTCATCACGATCATTATTTAAGC 55 - 435 
H8_E_103OUT 8 TACCAAGCTCATGTTCCTTTCA CCTCATCACGATCATTATTTAAGC 55 270 3272 
H8_E_113IN 8 AACCCTGTGCTCTCTGAAACAT CATAACCCCATACAAGGCTGTT 55 - 438 
H8_E_113OUT 8 ACACAAGTCACATGGTCAAACC CATAACCCCATACAAGGCTGTT 55 200 1000 
H14_E_33IN 8 AGTACCCAGGGACACAAACACT GGGAATGAAAACCACAAcTGAT 60 - 399 
H14_E_33OUT 8 ATTTGCAGGTGCTTTTGGTTAT GGGAATGAAAACCACAAcTGAT 60 308 2868 
H14_E_66IN 8 AGTACCCAGGGACACAAACACT AAAACTGTAGGATTGGCCAGAA 60 - 703 
H14_E_66OUT 8 CTACCAGTCTTGCCTTCAGCTT AAAACTGTAGGATTGGCCAGAA 60 225 3375 
H15_E_24IN 15 TCTGCCTAGGAAAACCAGAGAC AAAATCAGGTTGTTGCCATCAT 60 - 342 
H15_E_24OUT 15 TGCAAAGTGTGCGAAAATAATC AAAATCAGGTTGTTGCCATCAT 60 808 2471 
H15_E_29IN 15 AACCCTGTGCTCTCTGAAACAT CACAATGATTGGTATGGTCAGG 60 - 619 
H15_E_29OUT 15 TGTTGGGTAGGAAGAAATGAAA TCTCCTTTGTTGCCTCCTTTAT 60 379 2881 
H15_E_48IN 15 AACCCTGTGCTCTCTGAAACAT GCATCTTTGAAGCTGAATCTCAT 60 - 372 
H15_E_48OUT 15 CTTGCAAACTACAAATGGCTTG GCATCTTTGAAGCTGAATCTCAT 60 360 2878 
H16_E_86IN 16 AGTACCCAGGGACACAAACACT ATCTGCCCTGAATTTTATGCAC 60 - 561 
H16_E_86OUT 16 AGCTGTAGAAAGGCTTTTGGAA ATCTGCCCTGAATTTTATGCAC 60 457 1183 
H20_E_91IN 20 ACCTTCCCTCCACTATTGTCCT AATGACATAAGGCTGCCAACTT 60 - 466 
H20_E_91OUT 20 GATGAGTGGCAAGTTCATCAAA AATGACATAAGGCTGCCAACTT 60 363 1456 
H1_F_28IN 1 AACCCTGTGCTCTCTGAAACAT TCCTTGTTTTGCCTACACATGA 60 - 497 
H1_F_28OUT 1 AAACATTAGGCACGCAAAAACT TCTCTGGCATTACTGACGTGTT 60 504 2178 
H1_F_32IN 1 GCTCGTTAAGAGTCATCACCAA AGGGTGGATGATTCATGAGTTT 60 - 465 
H1_F_32OUT 1 CAGTACAGAAGCCGACCAAAA AGGGTGGATGATTCATGAGTTT 60 241 3101 




(Table A.2 cont.) 
H1_F_41OUT 1 CGGTGTCTGTTCTTGCTAAGTG TGCTTCCCCTTTGACTTCTATC 60 490 2945 
H1_F_58IN 1 TAATCAGGGACACAAACACTGC CAAGCATATCCCCACCTTAAAC 60 - 470 
H1_F_58OUT 1 GAATATGCCTGCATACGGAATC CAAGCATATCCCCACCTTAAAC 60 501 3471 
H1_F_67IN 1 TAATCAGGGACACAAACACTGC CACACATCCTGTCCATTCAACT 60 - 388 
H1_F_67OUT 1 GTTACAATGCCACGACTAGCAG CACACATCCTGTCCATTCAACT 60 303 2848 
H1_F_95IN 1 TGTGTCCACTCAGGGTTAAATG GaAGGAATGAGGATCACCAAAA 60 - 760 
H1_F_95OUT 1 GTGGTGGAAAACAACACAAATG GaAGGAATGAGGATCACCAAAA 60 1345 3791 
H1_F_127IN 1 TGTGTCCACTCAGGGTTAAATG TCTTCAGCAGATTCTCATTTGG 60 - 412 
H1_F_127OUT 1 TGCGCAATTCATAGTGTTTAGG TCTTCAGCAGATTCTCATTTGG 60 465 2660 
H1_F_159IN 1 TAATCAGGGACACAAACACTGC TTGATTGGGCTCTCAGTAGTCA 60 - 618 
H1_F_159OUT 1 TCTGCTTCACATCCTTTGAATG TTGATTGGGCTCTCAGTAGTCA 60 716 2247 
H1_F_160IN 1 TGTGTCCACTCAGGGTTAAATG GaAATACCATCTGGAGGGAGAA 60 - 667 
H1_F_160OUT 1 ACCACCTTTATGCCCTAGTCAA GaAATACCATCTGGAGGGAGAA 60 710 2396 
H1_F_163IN 1 AAGTACCCAGGGACACAAACAC TCTAACCTGTATCCTCCGCAGT 60 - 788 
H1_F_163OUT 1 TTGTAAGGGATTGGGGTTTATG TCTAACCTGTATCCTCCGCAGT 60 956 3290 
H1_F_171IN 1 TAATCAGGGACACAAACACTGC GGCGAACAGAAAACCAAAAATA 60 - 495 
H1_F_171OUT 1 CAGCAGCTGTTGAGTAAAGTGC GGCGAACAGAAAACCAAAAATA 60 683 3075 
H1_F_186IN 1 TGTGTCCACTCAGGGTTAAATG CCCTTTATATTGGGCATACAGTG 60 - 369 
H1_F_186OUT 1 AACAAACAGGCCTCTCAGTTTC CCCTTTATATTGGGCATACAGTG 60 473 2532 
H1_F_187IN 1 TGTGTCCACTCAGGGTTAAATG CACTTTTTCACAACGTGTGGTT 60 - 770 
H1_F_187OUT 1 TTCAAACAACTGACACCGAAAG CACTTTTTCACAACGTGTGGTT 60 712 2410 
H1_F_227IN 1 TGTGTCCACTCAGGGTTAAATG TTCATTTGCCCCACTTCTAAAC 60 - 348 
H1_F_227OUT 1 TTTGGGTAGAAAGATGAACCTG TTCATTTGCCCCACTTCTAAAC 60 139 2789 
H1_F_240IN 1 TAATCAGGGACACAAACACTGC TTAATTTTCCGAGAAACCTCCA 60 - 780 
H1_F_240OUT 1 GCAGACTATCCACCTGAAAAGG TTAATTTTCCGAGAAACCTCCA 60 796 2773 
H1_F_264IN 1 TAATCAGGGACACAAACACTGC TTCCTATTTAGCCCTCCCTTTC 60 - 348 
H1_F_264OUT 1 TTCCTGATGCATAGTAGCCTCTC TTCCTATTTAGCCCTCCCTTTC 60 530 1283 




(Table A.2 cont.) 
H1_F_281OUT 1 TCCATTGATGACAAACTTCCTG TTTTCCTACCTGTCCCACAAAT 60 402 2502 
H1_F_306IN 1 TCTGCCTAGGAAAACCAGAGAC CTGATGGGCAACCTTTTATCTC 60 - 459 
H1_F_306OUT 1 TTGTATTTTGGTCCTTCCCATC CTGATGGGCAACCTTTTATCTC 60 640 2275 
H1_F_309IN 1 TAATCAGGGACACAAACACTGC CATTTAAATCACCACGCTGAAG 60 - 485 
H1_F_309OUT 1 AGAGTGAAAGGTGACTCCAAGC CATTTAAATCACCACGCTGAAG 60 478 1055 
H2_F_9IN 2 TCTGCCTAGGAAAACCAGAGAC GCTGTTCAtGCCCAATAATGTA 60 - 577 
H2_F_9OUT 2 TTTGTCTAGACGGCAAATGATG GCTGTTCAtGCCCAATAATGTA 60 585 2544 
H2_F_56IN 2 TGTGTCCACTCAGGGTTAAATG ACCAAACAGGAAaTACCCTGAA 60 - 368 
H2_F_56OUT 2 GGGTAGGCTAACTGCTACAACG ACCAAACAGGAAaTACCCTGAA 60 114 2834 
H2_F_62IN 2 AACCCTGTGCTCTCTGAAACAT AGTCTCCCATCCACTTTGTGTT 60 - 532 
H2_F_62OUT 2 CTACAAAGCAGCACCCACATAC CTCCCATCCACTTTGTGTTAAA 60 358 2938 
H2_F_65IN 2 TAATCAGGGACACAAACACTGC TCAAGAAGTCCCAAAGGAATGT 60 - 423 
H2_F_65OUT 2 CATTTCCCTATCCTTCCTACCC TCAAGAAGTCCCAAAGGAATGT 60 429 2142 
H2_F_76IN 2 TGTGTCCACTCAGGGTTAAATG CCACGTATGCGTTTCTACTCAA 60 - 342 
H2_F_76OUT 2 GTCTCCAAGTCTATGGGGAGTG CCACGTATGCGTTTCTACTCAA 60 150 3152 
H2_F_86IN 2 TGGGATCTTGTTGATCTGTGAC ATGCCTGTTTCCAGGTTTATGT 60 - 438 
H2_F_86OUT 2 GGGAATGTCACCCAAAATAAGA ATGCCTGTTTCCAGGTTTATGT 60 155 1957 
H2_F_89IN 2 AGTACCCAGGGACACAAACACT ATGGAGATTCTGTTCTGGGAGA 60 - 397 
H2_F_89OUT 2 CTGTACCCCTCTTACCCCTTCT ATGGAGATTCTGTTCTGGGAGA 60 451 2044 
H2_F_93IN 2 TAATCAGGGACACAAACACTGC ACCATCACCCATGGAACTCTAA 60 - 303 
H2_F_93OUT 2 TCTCATTTGAGAAGAGCATGGA CCATCACCCATGGAACTCTAA 60 147 2477 
H2_F_117IN 2 TAATCAGGGACACAAACACTGC ATAGAATGGCCAGTTTCCTGAG 60 - 363 
H2_F_117OUT 2 GGTAAGGTCTTAGTGGGTCGTG ATAGAATGGCCAGTTTCCTGAG 60 435 1167 
H2_F_129IN 2 TGTGTCCACTCAGGGTTAAATG TCATGTTTGTGGATGGGATaAA 60 - 854 
H2_F_129OUT 2 TTGCTGACTGCTATCAGGGTTA TCATGTTTGTGGATGGGATaAA 60 687 2865 
H2_F_132IN 2 TAATCAGGGACACAAACACTGC CAGTTACTGATCCTGTGCTTGG 60 - 306 
H2_F_132OUT 2 CTCCTGGGACTATGTGTTAGGC CAGTTACTGATCCTGTGCTTGG 60 229 2039 




(Table A.2 cont.) 
H2_F_134OUT 2 TGTAGACTGTTTCCCCATACCC AATGCTCAATTCAATGGGTTCT 60 337 2031 
H2_F_136IN 2 TGTGTCCACTCAGGGTTAAATG GAAGCTTTCTTGTAGATTCCTTGG 60 - 386 
H2_F_136OUT 2 TCCTCCCTAAAGTTTGGAACAG GAAGCTTTCTTGTAGATTCCTTGG 60 170 2981 
H2_F_164IN 2 TGTGTCCACTCAGGGTTAAATG GCAACCAACAGGTGAAAATGTA 60 - 452 
H2_F_164OUT 2 AGGGAGTCACAAAGGGTGATTA GCAACCAACAGGTGAAAATGTA 60 386 1821 
H2_F_214IN 2 CAAGTAACCAGGGACACAAACA TGTCAGACAGTTCTGCCAAGTT 60 - 480 
H2_F_214OUT 2 TTCTGGCCTTCTGATTTGAGTT TGTCAGACAGTTCTGCCAAGTT 60 480 2555 
H2_F_237IN 2 TGCTCCTTAAGAGTCATCACCA GTCCTAAGAAATGGCCATCAAA 60 - 773 
H2_F_237OUT 2 ATATGCCCCCTTTGGATAATTT GTCCTAAGAAATGGCCATCAAA 60 564 3184 
H5_F_9IN 5 CTCTGTGAGAAACACCCAAGAA TCATCTGGGAGTCCAAATACCT 55 - 473 
H5_F_9OUT 5 TGTCTGCCCTACCGAGTAATTT GCTCTATTCAGCTGCATTTCCT 55 620 2696 
H5_F_90IN 5 TAATCAGGGACACAAACACTGC GTGGTAGGCAGGAAACACATTT 55 - 406 
H5_F_90OUT 5 AGCTGTTTCCATTTGACCATCT CACATCAAAGaTAAACCCCAAAA 55 360 2763 
H5_F_158IN 5 TAATCAGGGACACAAACACTGC GTGCACTAGGAAATGGTTGGTT 55 - 418 
H5_F_158OUT 5 TATCACCTCACATGCAAACTCC GTGCACTAGGAAATGGTTGGTT 55 320 2870 
H5_F_161IN 5 TGACCTTCCCTCCACTATTGTC CACATGGCCAATGCACTTATAG 55 - 499 
H5_F_161OUT 5 AGCATCAATGGGACAACCTAAA TGGGACTTAGACAAAAAGCTCA 55 790 2681 
H5_F_163IN 5 ATTGTGGTTTCGATTTGCATTT TGATCTCATTCCTGACCCTACC 55 - 431 
H5_F_163OUT 5 ACTTGGGAGTTTGCTTTTATGC TGATCTCATTCCTGACCCTACC 55 230 3064 
H5_F_171IN 5 TAATCAGGGACACAAACACTGC GAGGACATTTCTGTGATGACCA 55 - 597 
H5_F_171OUT 5 CATGAAAGCATGGCAGAAATAA TAACTGGTTTTTGGCATCACTG 55 950 3553 
H6_F_57IN 6 GGATCCTGTTGATCTGTGACCT GCAACAATTTTACTTCTTTGCTAGT 55 - 396 
H6_F_57OUT 6 AGGTGGTAGCATTGGTGAAATC GCAACAATTTTACTTCTTTGCTAGT 55 650 3065 
H6_F_70IN 6 TAATCAGGGACACAAACACTGC TGTGATTGGCATCAGAAGTAGG 55 - 403 
H6_F_70OUT 6 ATGCCAGGGAAAACTGTAATTC TGTGATTGGCATCAGAAGTAGG 55 560 2587 
H6_F_74IN 6 AGGAAAACGAGACCTTTGTTCA CAGGGGTACCTTGGAGATACTG 55 - 484 
H6_F_74OUT 6 AGCTCACATGCTACAGGGAAAT GGCCGACTGTATTTTATTCTGC 55 430 2295 




(Table A.2 cont.) 
H6_F_119OUT 6 GCCTCTAAACTGATCCAGGAAA AATCACAATCGTGTCTCCTCCT 55 530 2361 
H6_F_124IN 6 TAATCAGGGACACAAACACTGC AGCCTCCAAGAGCTTTTCATTT 55 - 250 
H6_F_124OUT 6 CCATGAACAACACCCATAAGAT AGCCTCCAAGAGCTTTTCATTT 55 330 2913 
H6_F_172IN 6 TAATCAGGGACACAAACACTGC TTGTGCCAGATATCCACACATT 55 - 442 
H6_F_172OUT 6 ATGGCAAACCTGCTCTCCTAT TTGTGCCAGATATCCACACATT 55 390 1189 
H7_F_10IN 7 TGTGTCCACTCAGGGTTAAATG TGCTGCTaGtAGAAGAGGGTGA 55 - 441 
H7_F_10OUT 7 AATGAATCCCCAGAAATCTGAA TGCTGCTaGtAGAAGAGGGTGA 55 490 2751 
H7_F_22IN 7 AACCCTGTGCTCTCTGAAACAT GCATTGTGCTTCCTGTATAGCC 55 - 403 
H7_F_22OUT 7 ACTGTCATGGAACTCTGCTTGA GCATTGTGCTTCCTGTATAGCC 55 290 2125 
H7_F_35IN 7 GTGTCCACTCAGGGTTAAATGG GAGCCCATCTGAACGATAAAAG 55 - 527 
H7_F_35OUT 7 TTTAGGCCCAAATATGCAAAA ATCAATgTCTTCATCTGCTTGG 55 760 3164 
H7_F_43IN 7 AACCCTGTGCTCTCTGAAACAT CAACCATGTAAGAATGGACCTG 55 - 724 
H7_F_43OUT 7 AAAGTCGTGTGGACTCCTCATT CAACCATGTAAGAATGGACCTG 55 570 1372 
H7_F_61IN 7 TAATCAGGGACACAAACACTGC TGAGTCCTGTTTCCTGAAGTGA 55 - 342 
H7_F_61OUT 7 GCTAGTGGGCCTTTCTCAACTA TGAGTCCTGTTTCCTGAAGTGA 55 380 2700 
H7_F_95IN 7 ACCTTCCCTCCACTATTGTCCT TCCTGTCCATTCAGACACAGTC 55 - 1050 
H7_F_95OUT 7 CCTCCTTGTATTGAAGGTTGGA ATACCAGCCTTCCTGTGATGTT 55 1020 3426 
H7_F_148IN 7 TAATCAGGGACACAAACACTGC TCTGGTTGCTTGCAGAGAGTAA 55 - 771 
H7_F_148OUT 7 CATGCTTCAAGAGAACATCAGG TCTGGTTGCTTGCAGAGAGTAA 55 630 1401 
H8_F_62IN 8 TAATCAGGGACACAAACACTGC AGTTCCCAAAGAAATTCTGCAA 55 - 418 
H8_F_62OUT 8 TGACTGTTCACCATTTCTCTGG AAATTTCTCCTCCACTTgACCA 55 440 2783 
H8_F_65IN 8 TAATCAGGGACACAAACACTGC CCCTCATCCCTAGGTTACCACT 55 - 448 
H8_F_65OUT 8 CAATGACAAGTTTTCACCAGGA GATTCCTTCCACATTTGGCTAC 55 240 2258 
H8_F_89IN 8 TGTGTCCACTCAGGGTTAAATG GGTCAAAGGCAAAGATTACACC 55 - 486 
H8_F_89OUT 8 CAACGACAAAATCACCTAACGA GGTCAAAGGCAAAGATTACACC 55 670 2944 
H8_F_116IN 8 GCTCGTTAAGAGTCATCACCAA CCACTTACTTAGGGTGGCAGAG 55 - 482 





Table A.3: SVA-mediated transduction events. 
 
Locus 





Signal Source Locus 
H1_12 Chr1:11072683-11078215  154 AAGATTAATTCTA C AATAAA Chr6:107203895-107204048     
H1_26 Chr1:13344563-13350269  75 AAGATATTTTAA D AATAAA Chr9:19122832-19122907      
H1_E1 Chr1:23924000-23926310 218 CAAAAAACTC D AATAAA chr2: 85659919-85660140     
H1_71 Chr1:34047471-34053166  888 AAAAGGCAGTGGTC B AATAAA Chr3:110299525-110300418 
H1_133 Chr1:91960730-91966266 185 GAAAATAGTTTC B ATTAAA Chr6:88709515-88709693     
H1_167 Chr1:114643178-114648726  290 AAAAATGGCCATGCATT C ATTAAA Chr2: 80683450-80683738     
H1_177 Chr1:144037937-144043412  200 AAGAAATTCTCTTT B AATAAA Chr16:20258896-20259001     
H1_182 Chr1:146493810-146498800 35 AATAATGA E AATAAA chr3: 184810276-184810313 
H1_220 Chr1:165361782-165367271  126 AATAACCTACAATG F AATAAA Chr5:64049246- 64049371 
H1_225 Chr1:170819088-170824816  1275 AAAAAAGACAATGAC C ATTAAA Chr7:77055695-77056973    
H1_238 Chr1:179216698-179222278 63 AGAAGAATGAAACTGG C AATAAA Chr8:41355248-41355312      
H1_275 Chr1:209952047-209957618  55 AAAAAAACCTAGCC B AATAAA Chr7:51270016-51270078      
H1_292 Chr1:222955922-222961212  171 CTAAATG B ATTAAA Chr15:48628124-48628291     
H1_297 Chr1:227026280-227031574  90 AATTACTC A ATTAAA Chr1:152189751-152189840      
H1_311 Chr1:243470451-243475964  268 AAAAACCTGAATT C AATAAA Cannot be located 
H2_5 Chr2:3225256-3230915  546 AAGAATGTTCCAG D AATAAA Chr15:57437220-57437771     
H2_57 Chr2:42194679-42199868  52 AATACTGTCCTTGGC D AATAAA chr5:77478208-77478255 
H2_68 Chr2:44266043-44272053  60 AAAAAACAAAACTG D AATAAA Chr1:24080384-24080452 
H2_88 Chr2:62829327-62834890  356 AAGAAAATG C AATAAA Chr8:71064456-71064812     
H2_103 Chr2:74994781-75000744  355 AAAAGAAGACATTTAT D AATAAA Chr9:13260233-13260501 
H2_171 Chr2:161505334-161510901 694 CATTAA B AATAAA Chr11:116107770-116108489     
H2_183 Chr2:171206117-171211975  271 AGAAATGTA D AATAAA chr7:138616963-138620752 
H2_195 Chr2:183451095-183456704  282 AAAGAAAGAAAAAAGAAAGA D - Cannot be located 
H2_199 Chr2:187537495-187543478  47 AAAAAGTAGACAAAGG D AATAAA Cannot be located 
H2_204 Chr2:191495474-191501019  342 AAAGAACAAGA D AATAAA Cannot be located 
H3_3 Chr3:5258054-5261221  404 GAAAATGACCATAGTC B AATAAA Chr1:203445306-203445687     
H3_25 Chr3:20562739-20566286  223 AAGAGCATAGGAATA B - Chr3:109158020-109158237 
H3_49 Chr3:47309857-47313060  546 AAGAACAGTTAA C AATAAA Chr17:39303775-39304321     
H3_65 Chr3:57328376-57331772  219 AAAAAATTG A - Cannot be located 
H3_71 Chr3:60868969-60872340  254 AAAATCTAG B AATAAA Cannot be located 
H3_85 Chr3:82552887-82556759  571 AAGAAAGAAGTATTTTG D AATAAA Chr2:38522750-38523319     
H3_88 Chr3:95082344-95084344  1156 AAGAATCCTTGGAATA D AATAAA Chr15:68900010-68901191    
H3_112 Chr3:120280678-120284294  110 AAGAATCACTCAGCTTTTC B AATAAA Chr9:94622971-94623507     
H3_121 Chr3:123818278-123822338  1276 AAGAAAACATATTCAAG D ATTAAA chr11:82522905-82524171    
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H3_160 Chr3:151857099-151860070  215 AAAAAAAATACCAAACTG E AATAAA Chr4:39841974-39842190    
H3_164 Chr3:165821594-165825014 131 AAATGCTTTCTTG B ATTAAA Chr19:35077442-35077593     
H3_E2 Chr3:188062000-188070000 1853 GAAAAATATTGCAAATAG E - chr7:64165000-64173000 
H3_186 Chr3:191510367-191513912  938 AAAAAGCAACAAAGTA D AATAAA chr2:85625536-85628105 
H4_E1 Chr4:3575241-3578880 955 AAGAGTGCCCTGG D AATAAA chr2:85625536-85628105 
H4_23 Chr4:37406486-37409815  111 AAAAATGCAAC B AATAAA Chr7:139337393-139337496     
H4_40 Chr4:53244851-53248159  480 AAAAGCCAAAATTG D AATAAA Chr2:38924964-38925428     
H4_79 Chr4:99708467-99711905 60 AAAAGTATTTAC B AATAAA Cannot be located 
H4_97 Chr4:124190129-124194178  81 AAAAGAAGTGTCCA D AATAAA Chr20:21052132-21052212      
H4_127 Chr4:160379188-160382794  54 AAATGAAGCCAAAGA C AATAAA Chr3:180495477-180495530      
H4_135 Chr4:166517000-166520716  381 AAAATGAACCCTCTA D AATAAA Chr15_random:286803-287188   
H5_10 Chr5:34348618-34353881  280 TGAAAAAAAA F AATAAA Chr8:37709894-37710171     
H5_12 Chr5:37056065-37061859  288 GAAATTTAAAGATTAAG D - Chr15:32520492-32521791 
H5_27 Chr5:43131689-43136768  191 AAGAGATAACAAG E AATAAA Chr6:70514549-70514744     
H5_34 Chr5:45933546-45939230  430 AAATACACATGCTT C AATAAA Chr1:208414788-208415222     
H5_37 Chr5:53690457-53695993  353 GAAAATTTT D - Chr5:174548887-174549239     
H5_47 Chr5:59740254-59745831   654 AAAAAAAACTAATC D AATAAA Chr17: 59739365-59740046     
H5_49 Chr5:61822320-61828351  803 AAGAATATCCTTGGGGATG D ATTAAA Chr13:97480307-97480398      
H5_50 Chr5:62392931-62398379  580 AAGAATGCAAGC D AATAAA Chr4:78730367-78730945     
H5_84 Chr5:79678438-79684240  190 AGAAGGTGTGGTG D AATAAA Chr13:45244291-45244483     
H5_108 Chr5:111770194-111775451  105 AATAATAAACTGAC B AATAAA Chr7:65763902-65765531 
H5_113 Chr5:117691892-117697488  1120 AAGAAATAAAACATGC C AATAAA Chr10:23694301-23695466    
H5_142 Chr5:149075606-149081514  950 AATAACAGGTGGG D AATAAA chr2:85625536-85628105 
H6_4 Chr6:13239485-13245030  1364 GAAAATCTATTTGG B - Chr15:91533114-91534496    
H6_12 Chr6:21902346-21907323  510 AGAAAAATCTACAC D ATTAAA Chr9:19122832-19122907      
H6_62 Chr6:36953618-36959120  995 GAAAAAAACACCCTAGA C AATAAA chr5:151836834-151841126 
H6_88 Chr6:57219875-57225701  31 AAACAGTAGAAAAG A AATAAA Cannot be located 
H6_106 Chr6:74553753-74559319 233 GAAAATACATCATTT D AATAAA Cannot be located 
H6_109 Chr6:74957835-74963309 488 AAATATCTATAGAT C AATAAA Chr1:45671251-45671658     
H6_117 Chr6:86541229-86547014 49 AAGAAATACCTACATCA D AATAAA Chr17:57403012-57403741 
H6_128 Chr6:106344556-106350393  827 AAGAAATAGGGTTTGG D AATAAA Chr9:36907182-36908013     
H6_132 Chr6:108634010-108639720 1263 AAAAATC D AATAAA Chr20:18307880-18309168    
H7_8 Chr7:1943077-1948579  95 TAATGGA B AATAAA Chr10:98911789-98911852      
H7_31 Chr7:23415795-23421089  108 AAGACTGTCCCCTG E AATAAA Chr2:208186339-208186453 
H7_40 Chr7:27766522-27772100  711 GTTCATATGG B ATTAAA Chr9:120582327-120583037     
H7_48 Chr7:35975193-35980666  487 AGAAATCTTTCAGCTC D AATAAA Chr4:117160949-117161579     
H7_131 Chr7:111749636-111755222  487 GAAACTGCACCATT D - Chr8:1209659810-120966424     
H8_15 Chr8:28757716-28762851  28 AGAAAAATGTAGACATA E ATTAAA Chr19:20262373-20262400 
H8_53 Chr8:57231903-57237542  159 AACAATTTGGG D ATTAAA Chr13:41214642-41214798     
H8_56 Chr8:59636341-59641814  105 TAAACTGCACAAAG D ATTAAA Chr4:113957645-113957746     
  
 95
(Table A.3 cont.) 
H8_66 Chr8:66576335-66581826 214 AAAAACTGTAACAGTA C AATAAA Chr4:189147677-189147890     
H8_121 Chr8:142180678-142186349  81 AACAGGAAGGGGG D AATAAA Chr2:232560962-232561059      
H9_12 Chr9:15429389-15435216  119 AAAGACGTTA B ATTAAA Cannot be located 
H9_22 Chr9:29176016-29182063  213 AAAAATTGAAATGTA F - Multiple hits 
H10_54 Chr10:51457637-51462948  123 ATAAAAAATGA B AATAAA Chr6:113948949-113949071     
H10_E1 Chr10:95719506-95721700 190 AAAATGGCAAAGT D AATAAA chr13:45244291-45244483     
H10_110 Chr10:99263314-99268809  126 AGAAAGCCTCTAATA D AATAAA Chr4:79922959-79923097     
H10_111 Chr10:99574252-99579972  168 AAGAAATTCCAG D AATAAA Cannot be located 
H11_12 Chr11:8961191-8967424  174 AAAAACATCAATACGT E AATAAA Chr7:55948692-55948864     
H11_30 Chr11:41286985-41292377  78 AGAAAAATACTGCATTA F - Cannot be located 
H11_59 Chr11:60031723-60037248  52 AAAATGCAGTATG C AATAAA Chr6:63709499-63709555      
H11_72 Chr11:63712698-63718315  35 AAAAAAAA F AATAAA Chr6:33944792-33944830      
H11_95 Chr11:73370963-73377067 92 AAAATCTCATCTC D ATTAAA Chr13:97480307-97480398      
H11_108 Chr11:77368542-77373765 193 TAAAAGTG B AATAAA Chr13:42089242-42089434     
H11_147 Chr11:118913375-118919266  169 AAATCCTCAAG F AATAAA Cannot be located 
H12_16 Chr12:12455107-12460407  180 AAGAAAACCACAAAATC E AATAAA Cannot be located 
H12_83 Chr12:55640962-55646367  869 GAAAATGGCCA D AATAAA Chr7:127798873-127798988     
H12_93 Chr12:64852465-64857782  255 AAAACTATCATTG C AATAAA Cannot be located 
H12_97 Chr12:68437039-68442483 210 AAAGGAATGAACACACAGA C AATAAA Chr2:60842597- 60842805  
H12_107 Chr12:74619053-74624984  218 TAAATTGAAGAAGTG D AATAAA Chr2: 85659919-85660140     
H12_139 Chr12:109799626-109803710  726 AAAGAAAATTTTTGT D AATAAA Chr6:121778220-121778955     
H12_157 Chr12:121276675-121282528  277 AAAGAATGAATTGG D AATAAA Chr3:101328106-101328389     
H12_160 Chr12:122936805-122942646 45 AAAGAAATAGTCAAT D - Chr1:25935624-25935675 
H13_29 Chr13:39324557-39330730  910 GAAAGTGTGTAG D AATAAA chr2:85625536-85628105 
H13_47 Chr13:49447257-49453060 159 AAATGAGATTCTGGGTTGA E - Chr2:228557924-228558081     
H13_64 Chr13:94275916-94281454  137 AAATGTAT B ATTAAA ChrX:64611735-64611874     
H14_66 Chr14:63350597-63355414   423 GAAAATTCTT E AATAAA Chr12:117479181-117479602     
H14_74 Chr14:69831319-69836783  202 AAGAAGATTA B - Chr13:36588352-36588508     
H14_94 Chr14:84283545-84289072  667 AACAGCTCAGA D AATAAA Cannot be located 
H15_E1 Chr15:26892141-26896040 47 AGTAAGTGA D AATAAA chr6:157524769-157525308 
H15_44 Chr15:54115274-54121928  687 AAGAACTACAAACCT D AATAAA Chr12:45927804-45928495     
H15_67 Chr15:72734404-72739991  58 ATCTTTAGCAG D AATAAA Chr16:48605488-48605545      
H15_81 Chr15:82207766-82213760  59 AAAAATATTTTTCAG D AATAAA Chr19:11600774-11600831      
H16_54 Chr16:46993352-46999197   177 GAAAATATGGTATTATTG D AATAAA Chr6:96087742-96087929     
H16_57 Chr16:48226052-48231417  57 AGAAGGCCCT B AATAAA Chr6: 157695447-157695503  
H17_4 Chr17:1510528-1515946  55 TAAAAAAAAAAAAAAAG D AATAAA Chr6:157524769-157525308 
H17_E1 Chr17:16152950-16157899 160 AAAGAAAAAACAAATA D - chr8:48331385-48331632     
H17_76 Chr17:33665047-33670581 1666 AAGATACCTGA C - Chr17:7325026-7328043 
H18_4 Chr18:6814686-6820405   191 AAACTAAAGAG D ATTAAA Chr2:122302608-122302805     
H18_14 Chr18:11947018-11952697  79 AAACAAAACAAA D AATAAA Chr7:20516061-20516138      
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H18_33 Chr18:28977316-28982431  189 AGAAATCAGCTACCAGA C AATAAA Chr5:75862647-75862842     
H18_35 Chr18:43603811-43609310  432 AAAAAAAGCACA B - Chr3:134725327-134725908     
H18_55 Chr18:72481830-72487404  861 AAAAAGCAGAGTCTGGC D AATAAA chr15:32520492-32521791 
H19_4 Chr19:6303799-6309513  218 AAAAAACTTTAAAAACA D AATAAA chr2: 85659919-85660140     
H19_13 Chr19:11646074-11651703 50 CTGATGCTGA B - Chr15:70755113-70755162      
H19_23 Chr19:20107110-20112434  209 AAGAAAAAGCTCAG D AATAAA Chr19:12181220-12181427     
H19_54 Chr19:21838664-21843485  439 AAAAACTA F AATAAA Chr11:105262106-105262551     
H19_73 Chr19:23505479-23511030 145 AAGAGTACTCAGGTG C - Chr1:39567915-39568024     
H19_130 Chr19:58003981-58009847  462 AAAAAAAGA D ATTAAA Chr14:65277341-65277807     
H20_8 Chr20:4005511-4011746  1687 AAAAATCGTAAATGAG E ATTAAA chr7:64165000-64173000 
H20_15 Chr20:10367960-10373476 42 AAGAACCAATGAAATGG C AATAAA Chr5:139966458-139967147 
H20_34 Chr20:29418677-29424377  77 AAAAAAAAAGAAG D - Chr11:75679877-75679955      
H20_35 Chr20:29531868-29538199  193 AAAGTATGTT D AATAAA ChrX:29892360-29892499     
H20_49 Chr20:32837153-32843015  827 GCTAAAAAGA D AATAAA chr9:36907182-36908013     
H20_50 Chr20:32999960-33006196 79 AAAAATATTTTTT D ATTAAA Cannot be located 
H20_94 Chr20:60911415-60916916  59 TCTTGATTTT D AATAAA Chr7:23373870-23373922 
H21_17 Chr21:39447115-39452520  177 AAAAGAAAATTTTAG D - Chr8:121214904-121215086     
H21_19 Chr21:44095698-44101133 192 GATGGGGT B AATAAA Chr1: 67406283-67406479     
H22_27 Chr22:29349549-29355067  266 ATAAATTTTATT D ATTAAA Chr2:220001533-220001800     
H22_36 Chr22:33343826-33349519  221 AAGAAATTCTCTTCT D ATTAAA Chr4:40374497-40374687     
HX_E1 ChrX:41900446-41900529 60 AAAAAGCAGT D AATAAA Chr1:24080384-24080452 
HX_49 ChrX:51820024-51825615  319 GAAATATATTTTGTG D AATAAA Multiple hits 
HX_75 ChrX:67505999-67511635  1248 GAAACTACTAGTCTA B AATAAA ChrX:134898910-134900153    
HX_87 ChrX:69759789-69766198  444 AAAACTTGTGA A AATAAA Chr13:19286787-19287231     
HX_90 ChrX:70643679-70649223  364 AAGAATATACCTA B ATTAAA Chr2:191900881-191901253     
HX_100 ChrX:72496594-72502004 343 AAGAAGTCACAGTC D - Chr8:48331385-48331632     
HX_153 ChrX:143182789-143188347  1483 AGAAATGCAGTTTAA D AATAAA Chr19:54502025-54503544    
HX_160 ChrX:152871790-152877218 58 AAAAAGGCTAG B AATAAA ChrX:40908434-40908501      
 
 
Table A.4: Loci names, primers, annealing temperatures and amplicon sizes of the source loci without SVA elements. 
 
Locus Primer Chr. 5' Primer Sequence (5'-3') 3' Primer Sequence (5'-3') Annealing Product Size 
  Name       Temp Without SVA 
H1_12 IN_H1_12 6 AGTACCCAGGGACACAAACACT CAGCACTCAACTAAAGCCATTG 60 458 
  OUT_H1_12 6 ATCTTGCTTCACTTCGTCATCA CAGCACTCAACTAAAGCCATTG 60 581 
H1_26 IN_H1_26 9 CGCAGGGTCCTCTGCCTA TGGTTAACCTGATAATCCACGA 60 492 
  OUT_H1_26 9 TCATACATTCTTTTTCCTTGAGGTC TGGTTAACCTGATAATCCACGA 60 394 
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H1_133 IN_H1_133 6 AGTACCCAGGGACACAAACAC CCCAGCATTATTTTTCCTCAAC 60 595 
  OUT_H1_133 6 TTAATGGATCCTAATGGGCAAT ACTTTCTGCGTCAGCAAAGATT 60 577 
H1_167 IN_H1_167 2 AGTACCCAGGGACACAAACACT AGCCTCTATGGATCACGGATTA 60 503 
  OUT_H1_167 2 GGAGGATTGGATCACCAGATTA AGCCTCTATGGATCACGGATTA 60 434 
H1_220 IN_H1_220 5 AGTGCTCTCTGAAACATGTGCT TATTTTCCTCATGGAAGCATGG 60 499 
  OUT_H1_220 5 GATTTGTGTTGCATCCATTGTT CCTTTGCTCATTTTGGACTCAT 60 598 
H1_275 IN_H1_275 7 TCATCACCACTCCCTAATCTCA AAGCAGCTTCAACATGGAAAAT 60 480 
  OUT_H1_275 7 GAATGTTGCCATTTCTGAAACA TGAAGAAGTTCTGGTGGACTTG 60 442 
H2_68 IN_H2_68 1 AGTACCCAGGGACACAAACACT ACTCCATGGTGTGACACTCGTA 60 525 
  OUT_H2_68 1 GACTACTTTCCCCAAGGGACTC ACTCCATGGTGTGACACTCGTA 60 447 
H2_103 IN_H2_103 9 AGTACCCAGGGACACAAACACT TCTGGCACTCAAAAGACTAAACA 60 587 
  OUT_H2_103 9 GATCATCAAACACCCCAAGAGT ATAATCCAGAAAGGACATCTGC 60 597 
H5_12 IN_H5_12 15 AGTACCCAGGGACACAAACACT ACTGGAATAGGGGAAGTGATGA 60 353 
  OUT_H5_12 15  AGAACCGAGTGAAGGTAGCATT ACTGGAATAGGGGAAGTGATGA 60 547 
H5_27 IN_H5_27 6 AGTACCCAGGGACACAAACACT TCCCTTGTATGCAAACCTGAAT 60 531 
  OUT_H5_27 6 CTGAATATGCCACCTTCAAAAA TCCCTTGTATGCAAACCTGAAT 60 423 
H5_49 IN_H5_49 8 AGTACCCAGGGACACAAACACT GGAATTCTTAAAAGCTGCAACAA 60 932 
  OUT_H5_49 8  AACATTCTTTTTCCGGGAGGT GGAATTCTTAAAAGCTGCAACAA 60 837 
H5_50 IN_H5_50 4 AGTACCCAGGGACACAAACACT TAACATGGGGGAAGGACATAGT 60 898 
  OUT_H5_50 4 CTCTGTGCTGGAACTCTGAATG TAACATGGGGGAAGGACATAGT 60 848 
H5_84 IN_H5_84 13 CGCAGGGTCCTCTGCCTA TTGGAATATGATACTATGTGGCGAGA 55 392 
  OUT_H5_84 13 TGTCCGCACTCTTAGAACAAAA TGGAATATGATACTATGTGGCGAGA 60 567 
H6_109 IN_H6_109 1 ATGCTCTCTGAAACATGTGCTG CAAGCTAAGGAAGGAGGTTGAA 55 872 
  OUT_H6_109 1 TGATGATGTCGGGACTAGAAAG  TCAAGCTAAGGAAGGAGGTTGA 60 699 
H7_31 IN_H7_31 2 AGTACCCAGGGACACAAACACT CACGTGTCACTCCTCTTGTAGC 60 884 
  OUT_H7_31 2 TGAGATTTCTTTTGTGGCTTGTT GGTTTTATTAACCAATTCTATGAAGG 60 552 
H7_48 IN_H7_48 4 AGTACCCAGGGACACAAACACT GTGATTCCAGCACGCTTTAGAT 55 789 
  OUT_H7_48 4 AGAAAAAGATTAAGGAAGATAATTGC TTGGAATATCTGACGCTTTAACA 60 974 
H7_131 IN_H7_131 8 AGTACCCAGGGACACAAACACT TTGCTGATTTAAGGACAACCAA 60 696 
  OUT_H7_131 8 ATTCAGTGAAAAGAGGGTCCAA TTGCTGATTTAAGGACAACCAA 60 664 
H10_110 IN_H10_110 4 AGTACCCAGGGACACAAACACT GCGGAAAGTGTAAGGAAGTTTG 60 383 
  OUT_H10_110 4 TGTTGCAAAATAGGTGCATTTC  GCGGAAAGTGTAAGGAAGTTTG 60 405 
H11_12 IN_H11_12 7 AGTACCCAGGGACACAAACACT TGCCTGAATTTAACTTTTGCTG 60 436 
  OUT_H11_12 7  GAAGTTCATTGGAAGAGCAGGA ATGGTTACTGTCCCAATTCTGG 60 541 
H11_72 IN_H11_72 6 TGTGTCCACTCAGGGTTAAATG TGTGGATTCACTCACAGAAAGG 60 358 
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  OUT_H11_72 6 TTCAGGAAAAATTCCCACAAAG  TGTGGATTCACTCACAGAAAGG 60 394 
H11_95 IN_H11_95 13 AGTACCCAGGGACACAAACACT GAAAATATGCTCCCCAATGAGA 60 678 
  OUT_H11_95 13 CTTGACTAAATTATCTGAAAAGGGTTT  GAAAATATGCTCCCCAATGAGA 60 524 
H11_108 IN_H11_108 13 AGTACCCAGGGACACAAACACT TAAATAGCTGGCTCCTCACTCC 60 533 
  OUT_H11_108 13 CTGTGTGCCAATCCTGTTAATG TAAATAGCTGGCTCCTCACTCC 60 469 
H13_64 IN_H13_64 X AGTACCCAGGGACACAAACACT TTCTGTTCTCCATGACCACTTG 60 898 
  OUT_H13_64 X AGGCATTCTCAGTAACCTCAGC CTTGCATTCTGGACACTTCACT 60 558 
H14_66 IN_H14_66 12 GGATCCTGTTGATCTGTGACCT AATGACTCCCTTGCAGTCTTTC 60 861 
  OUT_H14_66 12 GCTAACCCATAACTGGTCCTTTC AATGACTCCCTTGCAGTCTTTC 60 846 
H16_54 IN_H16_54 6 GACACAAACACTGCGGAAGG TCTTGCCAAAAACCTCTAGCAT 60 400 
  OUT_H16_54 6 TGGAAGAACAGATACGCCATAA TCTTGCCAAAAACCTCTAGCAT 60 515 
H18_14 IN_H18_14 7 AGTACCCAGGGACACAAACACT TACAGTCTGCACCGGACAGTAG 60 380 
  OUT_H18_14 7 ATTGCCTATGCTGGAAAACAAT TACAGTCTGCACCGGACAGTAG 60 432 
H19_73 IN_H19_73 1 AGTACCCAGGGACACAAACACT ATGTTGGATAGGCAAAGTGTCA 60 523 
  OUT_H19_73 1 TCCCTGTGGAGTGAGGATAAGT  ATGTTGGATAGGCAAAGTGTCA 60 510 
H20_94 IN_H20_94 7 AGTACCCAGGGACACAAACACT ATTGAGGGGGAAATTAGAAAGC 60 432 
  OUT_H20_94 7 TTTGCATAGAAAACAAACCCTTT ATTGAGGGGGAAATTAGAAAGC 60 318 
H22_36 IN_H22_36 4 AGTACCCAGGGACACAAACACT CCTTTCCTCTTCATTCGCACTA 60 484 
  OUT_H22_36 4 GACTTTGAAATTCCAGGACACC  CCTTTCCTCTTCATTCGCACTA 60 369 
HX_30 IN_HX_30 1 AGTACCCAGGGACACAAACACT TCCATGGTGTGACACTCGTAAG 60 504 
  OUT_HX_30 1 GTGCAGCCATCACCATTAAGTA TCCATGGTGTGACACTCGTAAG 60 369 
 
 
Table A.5: Primer names, annealing temperatures and amplicon sizes for PCR amplification and sequencing of AMAC gene  
loci. 
 
Name Chr 5’ Primer Sequence (5’-3’) 3’ Primer Sequence (5’-3’) Annealing Product Sizes 
        Temp Empty Filled 
H17_AMAC1_SVA 17 GCAATTAAAAGATGGGTAACTCC CGAGATGGCAGCAGTACAGT 55  467 
H17_AMAC1_TD 17 TGTTCCGGCAAAGACAGAG ATGGATGCAAACTCTTTTCATTTT 55  599 
H17_AMAC1_BOTH 17 GCAATTAAAAGATGGGTAACTCC ACTTCAATGGATGCAAACTCTT 55 810 4059 
H8_AMAC1L2_SVA 8 ATATTGGTGAAGGTTTGGATGG GCAGCAGTACAGTCCAGCTTT 55  1211 
H8_AMAC1L2_TD 8 GTGGTTGTGGCCCTTATACTG TCTCAATATTATAATGTGCTATGGAAG 55  301 
H8_AMAC1L2_TD1 8 ACCAGAGACCTTTGTTCACTTGTT TCTCAATATTATAATGTGCTATGGAAG 50  1465 
H8_AMAC1L2_TD2 8 GCACTCCAATGAGGTCACAAT TCTCAATATTATAATGTGCTATGGAAG 50  1252 
  
 99
(Table A.5 cont.) 
H8_AMAC1L2_BOTH 8 ATATTGGTGAAGGTTTGGATGG TCTCAATATTATAATGTGCTATGGAAG 48 1200 4098 
H17_AMAC1L3_TD1 17 CAGACAAACTTTGGAGTCATGG GGTTCAAGTAGGGGTGACTGC 55  1190 
H17_AMAC1L3_TD3 17 CTATAGCTCCTGGTTGCTCCAT TGCAGAGAACGATAGACCAGAA 50  1071 
H17_AMAC1L3_TD4 17 GGACCTGGACTCTGGACACTAC AATGAGAACGGTCGTAGGACTT 55  1055 
H17_AMAC1L3_RHESUS1* 17 TCAGAGCTCCTTGCCTTAAAAC AATGGAGCAACCAGGAGCTAT 55  986 
H17_AMAC1L3_RHESUS2* 17 TATAGCTCCTGGTTGCTCCATT AAGCCAAATAGGAAGGCCACT 55  1074 
H17_AMAC1L3_RHESUS3* 17 AACAGTGGCCTTCCTATTTGG ACGGTCGTAGGACTTCCACTC 50   848 
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